ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-6794361,Neurexins and neuroligins,2/25,55/10899,0.006963457795018962,0.20909559404061706,0.17608050024473015,EPB41/EPB41L5,2
R-HSA-198725,Nuclear Events (kinase and transcription factor activation),2/25,61/10899,0.008509475821097462,0.20909559404061706,0.17608050024473015,RPS6KA5/NAB1,2
R-HSA-68877,Mitotic Prometaphase,3/25,204/10899,0.010972263873310193,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8/RAD21,3
R-HSA-380259,Loss of Nlp from mitotic centrosomes,2/25,70/10899,0.011089280386706254,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,2/25,70/10899,0.011089280386706254,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-8854518,AURKA Activation by TPX2,2/25,73/10899,0.012016860323217374,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,2/25,82/10899,0.014996039563053001,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-380287,Centrosome maturation,2/25,82/10899,0.014996039563053001,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-6794362,Protein-protein interactions at synapses,2/25,86/10899,0.01641236460076024,0.20909559404061706,0.17608050024473015,EPB41/EPB41L5,2
R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,2/25,88/10899,0.01714131612688661,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,2/25,94/10899,0.019409758148199292,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-5620912,Anchoring of the basal body to the plasma membrane,2/25,98/10899,0.02098875165956223,0.20909559404061706,0.17608050024473015,CEP70/SDCCAG8,2
R-HSA-2470946,Cohesin Loading onto Chromatin,1/25,10/10899,0.02271184298078721,0.20909559404061706,0.17608050024473015,RAD21,1
R-HSA-418889,Caspase activation via Dependence Receptors in the absence of ligand,1/25,10/10899,0.02271184298078721,0.20909559404061706,0.17608050024473015,DAPK1,1
R-HSA-2468052,Establishment of Sister Chromatid Cohesion,1/25,11/10899,0.024955593915260255,0.20909559404061706,0.17608050024473015,RAD21,1
R-HSA-9700645,ALK mutants bind TKIs,1/25,12/10899,0.027194399035771033,0.20909559404061706,0.17608050024473015,STRN,1
R-HSA-187037,Signaling by NTRK1 (TRKA),2/25,115/10899,0.028269430574721248,0.20909559404061706,0.17608050024473015,RPS6KA5/NAB1,2
R-HSA-1852241,Organelle biogenesis and maintenance,3/25,296/10899,0.02932644226413876,0.20909559404061706,0.17608050024473015,POLG2/CEP70/SDCCAG8,3
R-HSA-68884,Mitotic Telophase/Cytokinesis,1/25,13/10899,0.029428268790901657,0.20909559404061706,0.17608050024473015,RAD21,1
R-HSA-1362300,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,1/25,16/10899,0.03610037003334576,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-166520,Signaling by NTRKs,2/25,134/10899,0.037429360379849376,0.22187219190500948,0.18683974055158692,RPS6KA5/NAB1,2
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/25,17/10899,0.03831460239107476,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,1/25,18/10899,0.04052395131041131,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/25,19/10899,0.042728427113852274,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-9671555,Signaling by PDGFR in disease,1/25,20/10899,0.04492804010302054,0.22187219190500948,0.18683974055158692,STRN,1
R-HSA-5621575,CD209 (DC-SIGN) signaling,1/25,21/10899,0.04712280055870843,0.22187219190500948,0.18683974055158692,RPS6KA5,1
R-HSA-198753,ERK/MAPK targets,1/25,22/10899,0.04931271874091392,0.22187219190500948,0.18683974055158692,RPS6KA5,1
R-HSA-73980,RNA Polymerase III Transcription Termination,1/25,23/10899,0.051497804888884335,0.22187219190500948,0.18683974055158692,NFIB,1
R-HSA-69242,S Phase,2/25,163/10899,0.053274672841357854,0.22187219190500948,0.18683974055158692,RAD21/RBL2,2
R-HSA-379716,Cytosolic tRNA aminoacylation,1/25,24/10899,0.053678069221155256,0.22187219190500948,0.18683974055158692,LARS1,1
R-HSA-452723,Transcriptional regulation of pluripotent stem cells,1/25,24/10899,0.053678069221155256,0.22187219190500948,0.18683974055158692,PBX1,1
R-HSA-9013508,NOTCH3 Intracellular Domain Regulates Transcription,1/25,25/10899,0.055853521935589456,0.22187219190500948,0.18683974055158692,PBX1,1
R-HSA-1538133,G0 and Early G1,1/25,27/10899,0.060190033199279513,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,1/25,27/10899,0.060190033199279513,0.22187219190500948,0.18683974055158692,DAPK1,1
R-HSA-201451,Signaling by BMP,1/25,28/10899,0.062351112041260315,0.22187219190500948,0.18683974055158692,ZFYVE16,1
R-HSA-69205,G1/S-Specific Transcription,1/25,28/10899,0.062351112041260315,0.22187219190500948,0.18683974055158692,RBL2,1
R-HSA-9619665,EGR2 and SOX10-mediated initiation of Schwann cell myelination,1/25,28/10899,0.062351112041260315,0.22187219190500948,0.18683974055158692,NAB1,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,2/25,182/10899,0.06474073558485392,0.22187219190500948,0.18683974055158692,RAD21/CASP8AP2,2
R-HSA-525793,Myogenesis,1/25,30/10899,0.06665896672340244,0.22187219190500948,0.18683974055158692,SPAG9,1
R-HSA-2990846,SUMOylation,2/25,188/10899,0.06852291602593406,0.22187219190500948,0.18683974055158692,RAD21/CASP8AP2,2
R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,1/25,31/10899,0.0688057627333315,0.22187219190500948,0.18683974055158692,RPS6KA5,1
R-HSA-68886,M Phase,3/25,418/10899,0.06902690414822517,0.22187219190500948,0.18683974055158692,CEP70/SDCCAG8/RAD21,3
R-HSA-69275,G2/M Transition,2/25,196/10899,0.07367887507112655,0.2300750710856021,0.19374742828261232,CEP70/SDCCAG8,2
R-HSA-453274,Mitotic G2-G2/M phases,2/25,198/10899,0.07498743057604809,0.2300750710856021,0.19374742828261232,CEP70/SDCCAG8,2
R-HSA-5617833,Cilium Assembly,2/25,201/10899,0.07696456507787566,0.230893695233627,0.1944367959862122,CEP70/SDCCAG8,2
R-HSA-75105,Fatty acyl-CoA biosynthesis,1/25,38/10899,0.08370115265092481,0.24280229350432808,0.20446508926680262,CBR4,1
R-HSA-9031628,NGF-stimulated transcription,1/25,39/10899,0.08581030200952244,0.24280229350432808,0.20446508926680262,NAB1,1
R-HSA-74158,RNA Polymerase III Transcription,1/25,41/10899,0.09001462728854381,0.24280229350432808,0.20446508926680262,NFIB,1
R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,1/25,41/10899,0.09001462728854381,0.24280229350432808,0.20446508926680262,NFIB,1
R-HSA-8939211,ESR-mediated signaling,2/25,223/10899,0.09196034526176183,0.24280229350432808,0.20446508926680262,STRN/RAD21,2
R-HSA-379724,tRNA Aminoacylation,1/25,42/10899,0.09210982293394665,0.24280229350432808,0.20446508926680262,LARS1,1
R-HSA-6782315,tRNA modification in the nucleus and cytosol,1/25,43/10899,0.09420038703329747,0.24280229350432808,0.20446508926680262,TRIT1,1
R-HSA-3899300,SUMOylation of transcription cofactors,1/25,45/10899,0.09836765982434503,0.24280229350432808,0.20446508926680262,CASP8AP2,1
R-HSA-437239,Recycling pathway of L1,1/25,47/10899,0.10251652392404964,0.24280229350432808,0.20446508926680262,RPS6KA5,1
R-HSA-69231,Cyclin D associated events in G1,1/25,47/10899,0.10251652392404964,0.24280229350432808,0.20446508926680262,RBL2,1
R-HSA-69236,G1 Phase,1/25,47/10899,0.10251652392404964,0.24280229350432808,0.20446508926680262,RBL2,1
R-HSA-73762,RNA Polymerase I Transcription Initiation,1/25,47/10899,0.10251652392404964,0.24280229350432808,0.20446508926680262,RRN3,1
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/25,48/10899,0.10458407708493223,0.24342845528389395,0.20499238339696335,RBL2,1
R-HSA-9012852,Signaling by NOTCH3,1/25,49/10899,0.10664705727780632,0.24402292766955685,0.20549299172173208,PBX1,1
R-HSA-383280,Nuclear Receptor transcription pathway,1/25,52/10899,0.11280865688861963,0.2538194779993942,0.2137427183152793,NR1D2,1
R-HSA-9700206,Signaling by ALK in cancer,1/25,55/10899,0.11892944758852875,0.25895928103953836,0.21807097350697974,STRN,1
R-HSA-9725370,Signaling by ALK fusions and activated point mutants,1/25,55/10899,0.11892944758852875,0.25895928103953836,0.21807097350697974,STRN,1
R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,1/25,56/10899,0.12096068733495857,0.2592014728606255,0.21827492451421096,POLG2,1
R-HSA-375165,NCAM signaling for neurite out-growth,1/25,63/10899,0.13505401128164396,0.28440136445781455,0.23949588585921233,RPS6KA5,1
R-HSA-450294,MAP kinase activation,1/25,64/10899,0.13704954927702606,0.28440136445781455,0.23949588585921233,RPS6KA5,1
R-HSA-9614085,FOXO-mediated transcription,1/25,65/10899,0.1390406670682649,0.28440136445781455,0.23949588585921233,RBL2,1
R-HSA-9006931,Signaling by Nuclear Receptors,2/25,299/10899,0.14920989475145202,0.3006468028574033,0.2531762550378134,STRN/RAD21,2
R-HSA-448424,Interleukin-17 signaling,1/25,72/10899,0.15285551173829692,0.30346314830397186,0.25554791436123947,RPS6KA5,1
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/25,77/10899,0.16259270136121562,0.3036723114167552,0.25572405171937285,RAD21,1
R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,1/25,77/10899,0.16259270136121562,0.3036723114167552,0.25572405171937285,EYA1,1
R-HSA-9009391,Extra-nuclear estrogen signaling,1/25,77/10899,0.16259270136121562,0.3036723114167552,0.25572405171937285,STRN,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/25,78/10899,0.16452720352957384,0.3036723114167552,0.25572405171937285,STRN,1
R-HSA-5693606,DNA Double Strand Break Response,1/25,78/10899,0.16452720352957384,0.3036723114167552,0.25572405171937285,EYA1,1
R-HSA-1221632,Meiotic synapsis,1/25,79/10899,0.1664574151469621,0.3036723114167552,0.25572405171937285,RAD21,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/25,83/10899,0.1741355382367451,0.3134439688261412,0.26395281585359265,RBL2,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/25,85/10899,0.17794909272684323,0.31567416695264694,0.2658308774338079,RBL2,1
R-HSA-73772,RNA Polymerase I Promoter Escape,1/25,91/10899,0.18928859291110622,0.31567416695264694,0.2658308774338079,RRN3,1
R-HSA-1592230,Mitochondrial biogenesis,1/25,95/10899,0.1967646718921372,0.31567416695264694,0.2658308774338079,POLG2,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/25,97/10899,0.20047784799475243,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/25,97/10899,0.20047784799475243,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/25,97/10899,0.20047784799475243,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/25,103/10899,0.21151876679096904,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/25,104/10899,0.21334463107683677,0.31567416695264694,0.2658308774338079,STRN,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/25,104/10899,0.21334463107683677,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/25,105/10899,0.21516643600718222,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/25,105/10899,0.21516643600718222,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/25,106/10899,0.21698419023173487,0.31567416695264694,0.2658308774338079,STRN,1
R-HSA-72306,tRNA processing,1/25,107/10899,0.21879790238259234,0.31567416695264694,0.2658308774338079,TRIT1,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/25,108/10899,0.22060758107425615,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/25,110/10899,0.22421487245022687,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-73854,RNA Polymerase I Promoter Clearance,1/25,110/10899,0.22421487245022687,0.31567416695264694,0.2658308774338079,RRN3,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/25,110/10899,0.22421487245022687,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-73864,RNA Polymerase I Transcription,1/25,112/10899,0.2278061329250154,0.31567416695264694,0.2658308774338079,RRN3,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/25,113/10899,0.22959577292472577,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/25,113/10899,0.22959577292472577,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/25,113/10899,0.22959577292472577,0.31567416695264694,0.2658308774338079,STRN,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/25,116/10899,0.23494083403678145,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/25,116/10899,0.23494083403678145,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-1500620,Meiosis,1/25,118/10899,0.2384844104120103,0.31567416695264694,0.2658308774338079,RAD21,1
R-HSA-2408522,Selenoamino acid metabolism,1/25,118/10899,0.2384844104120103,0.31567416695264694,0.2658308774338079,LARS1,1
R-HSA-373760,L1CAM interactions,1/25,119/10899,0.24025028461103615,0.31567416695264694,0.2658308774338079,RPS6KA5,1
R-HSA-112316,Neuronal System,2/25,410/10899,0.2418353353049328,0.31567416695264694,0.2658308774338079,EPB41/EPB41L5,2
R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,1/25,121/10899,0.24377024706189898,0.31567416695264694,0.2658308774338079,PBX1,1
R-HSA-5619507,Activation of HOX genes during differentiation,1/25,121/10899,0.24377024706189898,0.31567416695264694,0.2658308774338079,PBX1,1
R-HSA-9006936,Signaling by TGFB family members,1/25,122/10899,0.24552435207428092,0.31567416695264694,0.2658308774338079,ZFYVE16,1
R-HSA-2500257,Resolution of Sister Chromatid Cohesion,1/25,126/10899,0.2525017921126185,0.3215824710868254,0.27080629144153723,RAD21,1
R-HSA-69206,G1/S Transition,1/25,131/10899,0.26113650926901577,0.32947129674128156,0.2774495130452898,RBL2,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/25,142/10899,0.27979711073302116,0.348610761648029,0.29356695717728765,RPS6KA5,1
R-HSA-1474165,Reproduction,1/25,143/10899,0.28147091125655677,0.348610761648029,0.29356695717728765,RAD21,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/25,146/10899,0.28646993612391736,0.35157673978844406,0.2960646229797424,RPS6KA5,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/25,149/10899,0.2914355631485722,0.3532701544798496,0.2974906564040839,RBL2,1
R-HSA-9018519,Estrogen-dependent gene expression,1/25,150/10899,0.2930833874203197,0.3532701544798496,0.2974906564040839,RAD21,1
R-HSA-168898,Toll-like Receptor Cascades,1/25,168/10899,0.32212264720720196,0.38146102958747596,0.321230340705243,RPS6KA5,1
R-HSA-5693532,DNA Double-Strand Break Repair,1/25,168/10899,0.32212264720720196,0.38146102958747596,0.321230340705243,EYA1,1
R-HSA-8978868,Fatty acid metabolism,1/25,177/10899,0.3362093688402753,0.3946805634211928,0.3323625797231097,CBR4,1
R-HSA-109581,Apoptosis,1/25,180/10899,0.3408421733594933,0.39666977072009996,0.33403770165903157,DAPK1,1
R-HSA-72163,mRNA Splicing - Major Pathway,1/25,185/10899,0.3484946147229684,0.4021091708341943,0.33861824912353206,DDX46,1
R-HSA-2467813,Separation of Sister Chromatids,1/25,191/10899,0.35756499386160423,0.409040268333398,0.34445496280707205,RAD21,1
R-HSA-72172,mRNA Splicing,1/25,193/10899,0.3605614217161064,0.409040268333398,0.34445496280707205,DDX46,1
R-HSA-5357801,Programmed Cell Death,1/25,210/10899,0.3854950289457597,0.4336819075639797,0.3652058168959829,DAPK1,1
R-HSA-157118,Signaling by NOTCH,1/25,236/10899,0.4218321512276827,0.46447430278442653,0.39113625497635923,PBX1,1
R-HSA-68882,Mitotic Anaphase,1/25,236/10899,0.4218321512276827,0.46447430278442653,0.39113625497635923,RAD21,1
R-HSA-2555396,Mitotic Metaphase and Anaphase,1/25,237/10899,0.42318769809247747,0.46447430278442653,0.39113625497635923,RAD21,1
R-HSA-8951664,Neddylation,1/25,240/10899,0.4272360571124827,0.46513602992084807,0.3916934988807142,FBXO11,1
R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1/25,246/10899,0.435251097784052,0.4700711856067762,0.39584941945833785,DDX46,1
R-HSA-1257604,PIP3 activates AKT signaling,1/25,267/10899,0.4624644095311343,0.49549758164050106,0.4172611213814746,STRN,1
R-HSA-72766,Translation,1/25,291/10899,0.492024185903268,0.5230178354089857,0.4404360719233563,LARS1,1
R-HSA-9006925,Intracellular signaling by second messengers,1/25,309/10899,0.51316325182599,0.5370313100504547,0.45223689267406714,STRN,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/25,309/10899,0.51316325182599,0.5370313100504547,0.45223689267406714,FBXO11,1
R-HSA-73894,DNA Repair,1/25,336/10899,0.5432959648215743,0.5641919634685579,0.4751090218682594,EYA1,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/25,362/10899,0.5706149958681762,0.5880383545206397,0.49519019328053865,RBL2,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/25,374/10899,0.5826880080345032,0.5959309173080146,0.5018365619435913,LARS1,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/25,381/10899,0.5895793887934001,0.5984452442639776,0.5039538899065075,FBXO11,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/25,433/10899,0.6374594246333927,0.6422165845187164,0.5408139659104982,STRN,1
R-HSA-449147,Signaling by Interleukins,1/25,473/10899,0.6705924573767568,0.6705924573767568,0.5647094377909531,RPS6KA5,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,4/14,200/4383,0.0029350028695274482,0.013207512912873517,0.010813168466680073,FOXN3/RPS6KA5/RAD21/CASP8AP2,4
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,4/14,200/4383,0.0029350028695274482,0.013207512912873517,0.010813168466680073,STRN/PTBP2/SDCCAG8/CBR4,4
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,2/14,144/4383,0.0753559724667894,0.22606791740036822,0.18508484465527225,NR1D2/NFIB,2
HALLMARK_SPERMATOGENESIS,HALLMARK_SPERMATOGENESIS,1/14,135/4383,0.3550955514905403,0.4804857216730888,0.39338012300720726,MLLT10,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/14,158/4383,0.40236573141845533,0.4804857216730888,0.39338012300720726,POLG2,1
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,1/14,199/4383,0.47874154903601995,0.4804857216730888,0.39338012300720726,EPB41,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/14,200/4383,0.4804857216730888,0.4804857216730888,0.39338012300720726,RAD21,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/14,200/4383,0.4804857216730888,0.4804857216730888,0.39338012300720726,EPB41,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/14,200/4383,0.4804857216730888,0.4804857216730888,0.39338012300720726,KLHL24,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,8/45,289/21728,1.250817038882182e-7,9.83142192561395e-5,7.952563068261451e-5,FOXN3/PBX1/PER3/KLHL24/FBXO11/NFIB/RNF38/DDX46,8
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,6/45,254/21728,1.3372742841370063e-5,0.0052554879366584345,0.004251124566414482,NR1D2/PBX1/EYA1/PER3/KLHL24/NFIB,6
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,5/45,224/21728,9.724003583884846e-5,0.025476889389778296,0.02060806373567174,MLLT10/KHDC4/SPAG9/PER3/ZNF493,5
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,6/45,428/21728,2.3978362164801305e-4,0.042944879375634015,0.034737789129346386,RSBN1/NAB1/FMR1/FBXO11/RNF38/DDX46,6
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,2/45,12/21728,2.7318625557019096e-4,0.042944879375634015,0.034737789129346386,POLG2/CBR4,2
RODRIGUES_NTN1_TARGETS_UP,RODRIGUES_NTN1_TARGETS_UP,2/45,17/21728,5.592310269920257e-4,0.055291590969869,0.04472495104566877,FBXO11/NFIB,2
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,5/45,339/21728,6.572234865673718e-4,0.055291590969869,0.04472495104566877,POLG2/DAPK1/PTBP2/TSC22D2/RNF38,5
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,4/45,194/21728,6.895068080061309e-4,0.055291590969869,0.04472495104566877,NR1D2/PER3/FMR1/CASP8AP2,4
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,2/45,19/21728,7.013002040099225e-4,0.055291590969869,0.04472495104566877,NR1D2/KLHL24,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,3/45,84/21728,7.034553558507506e-4,0.055291590969869,0.04472495104566877,TSC22D2/VPS13B/NFIB,3
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,4/45,202/21728,8.017773180367499e-4,0.05729063381608049,0.046341961731502096,PBX1/CEP70/KLHL24/DDX46,4
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,4/45,220/21728,0.001100683129517472,0.060674975536828005,0.04907953023201301,MLLT10/KLHL23/NFIB/RRN3,4
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,2/45,24/21728,0.0011244936872385274,0.060674975536828005,0.04907953023201301,PBX1/RBL2,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,3/45,99/21728,0.0011331765065015409,0.060674975536828005,0.04907953023201301,FOXN3/EYA1/PTBP2,3
BROWNE_HCMV_INFECTION_12HR_DN,BROWNE_HCMV_INFECTION_12HR_DN,3/45,100/21728,0.001166539462186336,0.060674975536828005,0.04907953023201301,NR1D2/CBR4/VPS13B,3
PYEON_HPV_POSITIVE_TUMORS_UP,PYEON_HPV_POSITIVE_TUMORS_UP,3/45,102/21728,0.001235114005838738,0.060674975536828005,0.04907953023201301,NR1D2/PER3/CASP8AP2,3
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,5/45,401/21728,0.0013906193159077174,0.06429569307667446,0.05200830135035673,STRN/RSBN1/RAD21/ZFYVE16/KLHL24,5
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,4/45,244/21728,0.0016108665339145975,0.07034117198093742,0.056898443654059466,NR1D2/SPAG9/PTBP2/KLHL24,4
WEIGEL_OXIDATIVE_STRESS_RESPONSE,WEIGEL_OXIDATIVE_STRESS_RESPONSE,2/45,33/21728,0.0021258802285094784,0.08794430840044475,0.07113748797893213,DAPK1/RBL2,2
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,5/45,451/21728,0.002324642413209447,0.09135844683913126,0.07389915881992137,STRN/NAB1/LARS1/CEP170/RRN3,5
WP_PRION_DISEASE_PATHWAY,WP_PRION_DISEASE_PATHWAY,2/45,37/21728,0.002667443743393856,0.09983860868131289,0.0807586977949819,RAD21/RFX5,2
WP_BLADDER_CANCER,WP_BLADDER_CANCER,2/45,41/21728,0.0032670236795286282,0.10175200126013122,0.08230642662531037,RPS6KA5/DAPK1,2
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,3/45,145/21728,0.003364802415416987,0.10175200126013122,0.08230642662531037,FOXN3/PBX1/EPB41L5,3
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,4/45,300/21728,0.0034004114953097575,0.10175200126013122,0.08230642662531037,STRN/RSBN1/VPS13B/CEP170,4
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,2/45,42/21728,0.0034258719008165945,0.10175200126013122,0.08230642662531037,RPS6KA5/DAPK1,2
ONO_FOXP3_TARGETS_DN,ONO_FOXP3_TARGETS_DN,2/45,42/21728,0.0034258719008165945,0.10175200126013122,0.08230642662531037,FOXN3/RBL2,2
CORONEL_RFX7_DIRECT_TARGETS_UP,CORONEL_RFX7_DIRECT_TARGETS_UP,2/45,44/21728,0.003754208697892882,0.10175200126013122,0.08230642662531037,RPS6KA5/RFX5,2
NAKAYAMA_FRA2_TARGETS,NAKAYAMA_FRA2_TARGETS,2/45,44/21728,0.003754208697892882,0.10175200126013122,0.08230642662531037,NR1D2/KLHL24,2
STREICHER_LSM1_TARGETS_UP,STREICHER_LSM1_TARGETS_UP,2/45,44/21728,0.003754208697892882,0.10175200126013122,0.08230642662531037,FOXN3/PBX1,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,2/45,49/21728,0.004636435305955487,0.12147460501603376,0.09825989209814436,POLG2/ZFYVE16,2
BECKER_TAMOXIFEN_RESISTANCE_DN,BECKER_TAMOXIFEN_RESISTANCE_DN,2/45,54/21728,0.0056049022497419105,0.14211139252571425,0.11495283391660828,CEP170/NFIB,2
VERHAAK_GLIOBLASTOMA_PRONEURAL,VERHAAK_GLIOBLASTOMA_PRONEURAL,3/45,177/21728,0.005867516443449989,0.1432909906335934,0.11590700193208843,EPB41/RAD21/CRB1,3
REACTOME_NEUREXINS_AND_NEUROLIGINS,REACTOME_NEUREXINS_AND_NEUROLIGINS,2/45,56/21728,0.00601603395789896,0.1432909906335934,0.11590700193208843,EPB41/EPB41L5,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,3/45,184/21728,0.006529946543983376,0.15095699951679215,0.12210797871721234,RPS6KA5/ZFYVE16/KLHL24,3
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,2/45,60/21728,0.006878378138392704,0.15446872047933327,0.12494858332599076,PBX1/EYA1,2
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2/45,61/21728,0.007102232240022496,0.15472783568173687,0.12515817965952733,RPS6KA5/NAB1,2
GEORGES_CELL_CYCLE_MIR192_TARGETS,GEORGES_CELL_CYCLE_MIR192_TARGETS,2/45,62/21728,0.007329365581595854,0.15472783568173687,0.12515817965952733,RAD21/NFIB,2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,3/45,199/21728,0.008094983079518725,0.15472783568173687,0.12515817965952733,SPAG9/CBR4/EPB41L5,3
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,2/45,66/21728,0.008270413593470749,0.15472783568173687,0.12515817965952733,PBX1/RBL2,2
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,2/45,66/21728,0.008270413593470749,0.15472783568173687,0.12515817965952733,TSC22D2/FBXO11,2
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,3/45,201/21728,0.008318907059856835,0.15472783568173687,0.12515817965952733,DAPK1/EPB41/TSC22D2,3
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,2/45,67/21728,0.00851373518006785,0.15472783568173687,0.12515817965952733,DAPK1/NFIB,2
REACTOME_MITOTIC_PROMETAPHASE,REACTOME_MITOTIC_PROMETAPHASE,3/45,203/21728,0.008546464103424618,0.15472783568173687,0.12515817965952733,CEP70/SDCCAG8/RAD21,3
PAL_PRMT5_TARGETS_UP,PAL_PRMT5_TARGETS_UP,3/45,204/21728,0.008661609122132853,0.15472783568173687,0.12515817965952733,FMR1/NFIB/CASP8AP2,3
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,3/45,207/21728,0.00901252933178574,0.15741884566185757,0.127334917342657,EPB41/LARS1/RFX5,3
REACTOME_AURKA_ACTIVATION_BY_TPX2,REACTOME_AURKA_ACTIVATION_BY_TPX2,2/45,72/21728,0.009778015470621449,0.16352170552996723,0.1322714746753719,CEP70/SDCCAG8,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,2/45,72/21728,0.009778015470621449,0.16352170552996723,0.1322714746753719,NR1D2/KLHL24,2
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,2/45,73/21728,0.01004031086392035,0.16441009039669574,0.1329900824957871,PBX1/EPB41,2
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,2/45,75/21728,0.010574232986581122,0.16961932913168903,0.1372037964316863,SDCCAG8/CEP170,2
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,3/45,223/21728,0.011024564574133632,0.16969688265263766,0.1372665288900404,KHDC4/PTBP2/TSC22D2,3
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,3/45,225/21728,0.011292875476614554,0.16969688265263766,0.1372665288900404,PBX1/SPAG9/ZBTB5,3
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,3/45,226/21728,0.011428443480085518,0.16969688265263766,0.1372665288900404,MLLT10/CBR4/RFX5,3
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,2/45,79/21728,0.011679027954509088,0.16969688265263766,0.1372665288900404,NR1D2/FMR1,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,4/45,428/21728,0.011704636845945355,0.16969688265263766,0.1372665288900404,RPS6KA5/PER3/KLHL24/NFIB,4
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,2/45,81/21728,0.012249688166482612,0.16969688265263766,0.1372665288900404,CEP70/SDCCAG8,2
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,2/45,82/21728,0.012539537753505855,0.16969688265263766,0.1372665288900404,DAPK1/NFIB,2
RIZ_ERYTHROID_DIFFERENTIATION,RIZ_ERYTHROID_DIFFERENTIATION,2/45,82/21728,0.012539537753505855,0.16969688265263766,0.1372665288900404,POLG2/PER3,2
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,4/45,438/21728,0.012651596794697908,0.16969688265263766,0.1372665288900404,PBX1/DAPK1/EYA1/TSC22D2,4
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,3/45,236/21728,0.012836185304862038,0.16969688265263766,0.1372665288900404,RSBN1/CEP70/RAD21,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,2/45,85/21728,0.013427007218838714,0.16969688265263766,0.1372665288900404,TSC22D2/VPS13B,2
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,3/45,241/21728,0.013575761254524355,0.16969688265263766,0.1372665288900404,EPB41/FMR1/RNF38,3
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,3/45,242/21728,0.013726548276441042,0.16969688265263766,0.1372665288900404,PBX1/EPB41/CEP70,3
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,2/45,86/21728,0.013728760498663742,0.16969688265263766,0.1372665288900404,ZFYVE16/RBL2,2
REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2/45,87/21728,0.014033457216821182,0.16969688265263766,0.1372665288900404,EPB41/EPB41L5,2
REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,2/45,87/21728,0.014033457216821182,0.16969688265263766,0.1372665288900404,CEP70/SDCCAG8,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,2/45,91/21728,0.01528142073340152,0.18198782873414537,0.14720858250358082,KLHL24/EPB41L5,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,4/45,466/21728,0.015561056906025729,0.18255210041994363,0.14766501761570366,FOXN3/DAPK1/CEP170/NFIB,4
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,2/45,93/21728,0.015922729142588105,0.18349726774249933,0.14842955633650676,RBL2/CASP8AP2,2
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,4/45,472/21728,0.016235145627464184,0.18349726774249933,0.14842955633650676,KHDC4/RSBN1/RAD21/PER3,4
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,2/45,95/21728,0.016575452938571822,0.18349726774249933,0.14842955633650676,FOXN3/NFIB,2
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,2/45,95/21728,0.016575452938571822,0.18349726774249933,0.14842955633650676,CEP70/SDCCAG8,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,3/45,263/21728,0.01711587330864991,0.18359291426206106,0.1485069240850206,EYA1/RBL2/CEP170,3
REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,2/45,97/21728,0.01723949110062515,0.18359291426206106,0.1485069240850206,CEP70/SDCCAG8,2
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,3/45,265/21728,0.01746097436391261,0.18359291426206106,0.1485069240850206,RPS6KA5/DAPK1/EPB41,3
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,4/45,483/21728,0.017518407849433308,0.18359291426206106,0.1485069240850206,RSBN1/PTBP2/PER3/MKRN3,4
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,2/45,100/21728,0.018256543292561073,0.18512000669478035,0.1497421776398116,ZBTB5/NFIB,2
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,3/45,271/21728,0.018519684608991175,0.18512000669478035,0.1497421776398116,TSC22D2/ZFYVE16/RBL2,3
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,2/45,102/21728,0.018948429385989615,0.18512000669478035,0.1497421776398116,PBX1/KLHL24,2
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,3/45,279/21728,0.01998603720429941,0.18512000669478035,0.1497421776398116,FOXN3/EPB41/RFX5,3
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,2/45,105/21728,0.0200067882072065,0.18512000669478035,0.1497421776398116,DAPK1/CEP170,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,3/45,281/21728,0.020362418379066084,0.18512000669478035,0.1497421776398116,KLHL24/NFIB/RRN3,3
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,1/45,10/21728,0.020522859100516988,0.18512000669478035,0.1497421776398116,MLLT10,1
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,1/45,10/21728,0.020522859100516988,0.18512000669478035,0.1497421776398116,FOXN3,1
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,1/45,10/21728,0.020522859100516988,0.18512000669478035,0.1497421776398116,DAPK1,1
REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,1/45,10/21728,0.020522859100516988,0.18512000669478035,0.1497421776398116,DAPK1,1
REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,1/45,10/21728,0.020522859100516988,0.18512000669478035,0.1497421776398116,RAD21,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,2/45,107/21728,0.02072590405743088,0.18512000669478035,0.1497421776398116,PBX1/NFIB,2
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,2/45,107/21728,0.02072590405743088,0.18512000669478035,0.1497421776398116,CEP70/EPB41L5,2
VANTVEER_BREAST_CANCER_METASTASIS_DN,VANTVEER_BREAST_CANCER_METASTASIS_DN,2/45,109/21728,0.021455740807236424,0.1865910175282258,0.15093206721179642,MLLT10/RAD21,2
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,3/45,290/21728,0.02210468726101862,0.1865910175282258,0.15093206721179642,PBX1/CRB1/NFIB,3
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,1/45,11/21728,0.02255234944679574,0.1865910175282258,0.15093206721179642,DAPK1,1
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1/45,11/21728,0.02255234944679574,0.1865910175282258,0.15093206721179642,LARS1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,1/45,11/21728,0.02255234944679574,0.1865910175282258,0.15093206721179642,NAB1,1
REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1/45,11/21728,0.02255234944679574,0.1865910175282258,0.15093206721179642,RAD21,1
ROZANOV_MMP14_CORRELATED,ROZANOV_MMP14_CORRELATED,1/45,11/21728,0.02255234944679574,0.1865910175282258,0.15093206721179642,DAPK1,1
REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,3/45,296/21728,0.023310380190855354,0.18834969449900263,0.15235464775331137,POLG2/CEP70/SDCCAG8,3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,2/45,115/21728,0.02370861108083707,0.18834969449900263,0.15235464775331137,KHDC4/RAD21,2
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,2/45,116/21728,0.02409320381249287,0.18834969449900263,0.15235464775331137,NFIB/DDX46,2
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,1/45,12/21728,0.024577727918724923,0.18834969449900263,0.15235464775331137,DAPK1,1
REACTOME_ALK_MUTANTS_BIND_TKIS,REACTOME_ALK_MUTANTS_BIND_TKIS,1/45,12/21728,0.024577727918724923,0.18834969449900263,0.15235464775331137,STRN,1
SA_PROGRAMMED_CELL_DEATH,SA_PROGRAMMED_CELL_DEATH,1/45,12/21728,0.024577727918724923,0.18834969449900263,0.15235464775331137,CASP8AP2,1
WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,1/45,12/21728,0.024577727918724923,0.18834969449900263,0.15235464775331137,RAD21,1
PUJANA_BRCA_CENTERED_NETWORK,PUJANA_BRCA_CENTERED_NETWORK,2/45,118/21728,0.024870094775205576,0.18834969449900263,0.15235464775331137,RAD21/DDX46,2
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,2/45,119/21728,0.025262369452520694,0.18834969449900263,0.15235464775331137,FOXN3/ZFYVE16,2
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,2/45,120/21728,0.025657181284386984,0.18834969449900263,0.15235464775331137,CBR4/CASP8AP2,2
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,3/45,309/21728,0.026044030240474764,0.18834969449900263,0.15235464775331137,NR1D2/FOXN3/PER3,3
WP_CELL_CYCLE,WP_CELL_CYCLE,2/45,122/21728,0.026454369697795854,0.18834969449900263,0.15235464775331137,RAD21/RBL2,2
CONRAD_GERMLINE_STEM_CELL,CONRAD_GERMLINE_STEM_CELL,1/45,13/21728,0.0265990026582561,0.18834969449900263,0.15235464775331137,SPAG9,1
KEGG_CIRCADIAN_RHYTHM_MAMMAL,KEGG_CIRCADIAN_RHYTHM_MAMMAL,1/45,13/21728,0.0265990026582561,0.18834969449900263,0.15235464775331137,PER3,1
REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,1/45,13/21728,0.0265990026582561,0.18834969449900263,0.15235464775331137,RAD21,1
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,1/45,13/21728,0.0265990026582561,0.18834969449900263,0.15235464775331137,EPB41,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,2/45,125/21728,0.02766888994783099,0.193899300760269,0.15684368241489552,RAD21/RBL2,2
WHITFIELD_CELL_CYCLE_M_G1,WHITFIELD_CELL_CYCLE_M_G1,2/45,126/21728,0.02807868051516081,0.193899300760269,0.15684368241489552,CEP70/RAD21,2
HOEGERKORP_CD44_TARGETS_DIRECT_DN,HOEGERKORP_CD44_TARGETS_DIRECT_DN,1/45,14/21728,0.028616181791591866,0.193899300760269,0.15684368241489552,MLLT10,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,1/45,14/21728,0.028616181791591866,0.193899300760269,0.15684368241489552,PBX1,1
STEINER_ERYTHROCYTE_MEMBRANE_GENES,STEINER_ERYTHROCYTE_MEMBRANE_GENES,1/45,14/21728,0.028616181791591866,0.193899300760269,0.15684368241489552,EPB41,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,3/45,324/21728,0.029404324380760828,0.1941500718980968,0.15704652929750965,KLHL24/CEP170/NFIB,3
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,2/45,130/21728,0.029742289435581784,0.1941500718980968,0.15704652929750965,MLLT10/RSRC1,2
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,2/45,131/21728,0.030164246390561457,0.1941500718980968,0.15704652929750965,DAPK1/NFIB,2
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,3/45,329/21728,0.030573375762464973,0.1941500718980968,0.15704652929750965,PBX1/NFIB/CASP8AP2,3
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,2/45,132/21728,0.030588602582197637,0.1941500718980968,0.15704652929750965,EYA1/VPS13B,2
MURAKAMI_UV_RESPONSE_1HR_UP,MURAKAMI_UV_RESPONSE_1HR_UP,1/45,15/21728,0.030629273429216286,0.1941500718980968,0.15704652929750965,DAPK1,1
PID_LPA4_PATHWAY,PID_LPA4_PATHWAY,1/45,15/21728,0.030629273429216286,0.1941500718980968,0.15704652929750965,RPS6KA5,1
WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1/45,15/21728,0.030629273429216286,0.1941500718980968,0.15704652929750965,RPS6KA5,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,2/45,133/21728,0.03101534674452494,0.19469082290699752,0.1574839387114323,ZFYVE16/RBL2,2
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,2/45,134/21728,0.03144446764610904,0.19469082290699752,0.1574839387114323,RPS6KA5/NAB1,2
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,3/45,336/21728,0.03225104516148872,0.19469082290699752,0.1574839387114323,FOXN3/EYA1/KLHL24,3
UDAYAKUMAR_MED1_TARGETS_UP,UDAYAKUMAR_MED1_TARGETS_UP,2/45,136/21728,0.03230979491342962,0.19469082290699752,0.1574839387114323,CEP70/KLHL23,2
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,1/45,16/21728,0.03263828566592619,0.19469082290699752,0.1574839387114323,RBL2,1
WP_ID_SIGNALING_PATHWAY,WP_ID_SIGNALING_PATHWAY,1/45,16/21728,0.03263828566592619,0.19469082290699752,0.1574839387114323,RBL2,1
WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,1/45,16/21728,0.03263828566592619,0.19469082290699752,0.1574839387114323,RAD21,1
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,2/45,139/21728,0.03362533254860307,0.19469082290699752,0.1574839387114323,TSC22D2/KLHL24,2
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,2/45,140/21728,0.0340684799481014,0.19469082290699752,0.1574839387114323,NR1D2/KLHL24,2
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,2/45,141/21728,0.034513926426196315,0.19469082290699752,0.1574839387114323,PER3/RNF38,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/45,17/21728,0.03464322658085961,0.19469082290699752,0.1574839387114323,RBL2,1
SA_PTEN_PATHWAY,SA_PTEN_PATHWAY,1/45,17/21728,0.03464322658085961,0.19469082290699752,0.1574839387114323,RBL2,1
WP_SEROTONIN_AND_ANXIETY,WP_SEROTONIN_AND_ANXIETY,1/45,17/21728,0.03464322658085961,0.19469082290699752,0.1574839387114323,FMR1,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,2/45,145/21728,0.03631848446221083,0.19469082290699752,0.1574839387114323,STRN/VPS13B,2
BIOCARTA_PDZS_PATHWAY,BIOCARTA_PDZS_PATHWAY,1/45,18/21728,0.03664410423752518,0.19469082290699752,0.1574839387114323,EPB41,1
DORMOY_ELAVL1_TARGETS,DORMOY_ELAVL1_TARGETS,1/45,18/21728,0.03664410423752518,0.19469082290699752,0.1574839387114323,SPAG9,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,1/45,18/21728,0.03664410423752518,0.19469082290699752,0.1574839387114323,RBL2,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,2/45,146/21728,0.036775262630784844,0.19469082290699752,0.1574839387114323,POLG2/NFIB,2
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,2/45,148/21728,0.03769550970813466,0.19469082290699752,0.1574839387114323,CEP70/KLHL24,2
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,2/45,148/21728,0.03769550970813466,0.19469082290699752,0.1574839387114323,CEP70/KLHL24,2
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,3/45,359/21728,0.03809827931380104,0.19469082290699752,0.1574839387114323,EYA1/RFX5/NFIB,3
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,3/45,359/21728,0.03809827931380104,0.19469082290699752,0.1574839387114323,FOXN3/EPB41/EPB41L5,3
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,2/45,150/21728,0.038624606223033604,0.19469082290699752,0.1574839387114323,NAB1/KLHL23,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,3/45,361/21728,0.038630851987687544,0.19469082290699752,0.1574839387114323,LARS1/DDX46/RRN3,3
FARMER_BREAST_CANCER_CLUSTER_5,FARMER_BREAST_CANCER_CLUSTER_5,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,POLG2,1
KANG_DOXORUBICIN_RESISTANCE_DN,KANG_DOXORUBICIN_RESISTANCE_DN,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,NR1D2,1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,RAD21,1
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,PBX1,1
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,RBL2,1
WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,PTBP2,1
WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,RPS6KA5,1
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,1/45,19/21728,0.03864092668383157,0.19469082290699752,0.1574839387114323,TSC22D2,1
REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,1/45,20/21728,0.040633701952117796,0.20342732314881903,0.16455082788521053,STRN,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,2/45,155/21728,0.04098550468660113,0.20369259299996448,0.16476540266770934,PBX1/EPB41L5,2
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,3/45,371/21728,0.04135113051779862,0.20369259299996448,0.16476540266770934,EPB41/RFX5/CEP170,3
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,2/45,156/21728,0.04146414106869506,0.20369259299996448,0.16476540266770934,EYA1/KLHL24,2
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,1/45,21/21728,0.04262243805918198,0.20552905714427627,0.1662509046673937,NR1D2,1
LEE_INTRATHYMIC_T_PROGENITOR,LEE_INTRATHYMIC_T_PROGENITOR,1/45,21/21728,0.04262243805918198,0.20552905714427627,0.1662509046673937,CEP70,1
REACTOME_CD209_DC_SIGN_SIGNALING,REACTOME_CD209_DC_SIGN_SIGNALING,1/45,21/21728,0.04262243805918198,0.20552905714427627,0.1662509046673937,RPS6KA5,1
REACTOME_S_PHASE,REACTOME_S_PHASE,2/45,162/21728,0.044380278090339405,0.2099473916344956,0.16982486212298828,RAD21/RBL2,2
BIOCARTA_CREB_PATHWAY,BIOCARTA_CREB_PATHWAY,1/45,22/21728,0.04460714300631141,0.2099473916344956,0.16982486212298828,RPS6KA5,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,1/45,22/21728,0.04460714300631141,0.2099473916344956,0.16982486212298828,FBXO11,1
REACTOME_ERK_MAPK_TARGETS,REACTOME_ERK_MAPK_TARGETS,1/45,22/21728,0.04460714300631141,0.2099473916344956,0.16982486212298828,RPS6KA5,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,2/45,164/21728,0.04536895891986951,0.210448449865161,0.17023016434787364,EPB41/TSC22D2,2
CHEOK_RESPONSE_TO_HD_MTX_DN,CHEOK_RESPONSE_TO_HD_MTX_DN,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,CEP170,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,STRN,1
HINATA_NFKB_TARGETS_KERATINOCYTE_DN,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,DAPK1,1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,NFIB,1
STARK_HYPPOCAMPUS_22Q11_DELETION_DN,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,FOXN3,1
WP_GDNFRET_SIGNALING_AXIS,WP_GDNFRET_SIGNALING_AXIS,1/45,23/21728,0.04658782477931045,0.210448449865161,0.17023016434787364,EYA1,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,2/45,168/21728,0.04737078196794007,0.21090540263254304,0.1705997899960573,FMR1/NFIB,2
PUJANA_XPRSS_INT_NETWORK,PUJANA_XPRSS_INT_NETWORK,2/45,168/21728,0.04737078196794007,0.21090540263254304,0.1705997899960573,RAD21/DDX46,2
LIN_NPAS4_TARGETS_UP,LIN_NPAS4_TARGETS_UP,2/45,170/21728,0.04838376218404457,0.21090540263254304,0.1705997899960573,MKRN3/RRN3,2
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,1/45,24/21728,0.048564491348531025,0.21090540263254304,0.1705997899960573,LARS1,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,3/45,399/21728,0.04947123435363097,0.21090540263254304,0.1705997899960573,PBX1/RPS6KA5/TSC22D2,3
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,3/45,400/21728,0.049774787055832395,0.21090540263254304,0.1705997899960573,NBPF3/ZNF493/RNF38,3
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,2/45,173/21728,0.04991809250563088,0.21090540263254304,0.1705997899960573,KHDC4/RSBN1,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,2/45,173/21728,0.04991809250563088,0.21090540263254304,0.1705997899960573,FOXN3/RPS6KA5,2
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,2/45,174/21728,0.050433458770788774,0.21090540263254304,0.1705997899960573,DAPK1/KLHL24,2
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,1/45,25/21728,0.05053715066890141,0.21090540263254304,0.1705997899960573,TSC22D2,1
REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/45,25/21728,0.05053715066890141,0.21090540263254304,0.1705997899960573,PBX1,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,1/45,25/21728,0.05053715066890141,0.21090540263254304,0.1705997899960573,DAPK1,1
VALK_AML_CLUSTER_8,VALK_AML_CLUSTER_8,1/45,25/21728,0.05053715066890141,0.21090540263254304,0.1705997899960573,PBX1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,3/45,405/21728,0.05130639894315631,0.21090540263254304,0.1705997899960573,NR1D2/SPAG9/KLHL24,3
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,2/45,177/21728,0.051991187574349874,0.21090540263254304,0.1705997899960573,FBXO11/NFIB,2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,1/45,26/21728,0.05250581067995497,0.21090540263254304,0.1705997899960573,PBX1,1
JI_METASTASIS_REPRESSED_BY_STK11,JI_METASTASIS_REPRESSED_BY_STK11,1/45,26/21728,0.05250581067995497,0.21090540263254304,0.1705997899960573,PBX1,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/45,26/21728,0.05250581067995497,0.21090540263254304,0.1705997899960573,RAD21,1
REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,1/45,26/21728,0.05250581067995497,0.21090540263254304,0.1705997899960573,DAPK1,1
WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,1/45,26/21728,0.05250581067995497,0.21090540263254304,0.1705997899960573,PBX1,1
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,3/45,409/21728,0.052548242960342224,0.21090540263254304,0.1705997899960573,RPS6KA5/EPB41/EPB41L5,3
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,2/45,179/21728,0.0530392669078688,0.21090540263254304,0.1705997899960573,MLLT10/SPAG9,2
REACTOME_M_PHASE,REACTOME_M_PHASE,3/45,415/21728,0.05443843668275139,0.21090540263254304,0.1705997899960573,CEP70/SDCCAG8/RAD21,3
BIOCARTA_ERK_PATHWAY,BIOCARTA_ERK_PATHWAY,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,RPS6KA5,1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,FOXN3,1
LI_WILMS_TUMOR,LI_WILMS_TUMOR,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,EYA1,1
OHM_METHYLATED_IN_ADULT_CANCERS,OHM_METHYLATED_IN_ADULT_CANCERS,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,DAPK1,1
REACTOME_G0_AND_EARLY_G1,REACTOME_G0_AND_EARLY_G1,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,RBL2,1
VALK_AML_CLUSTER_7,VALK_AML_CLUSTER_7,1/45,27/21728,0.05447047930586035,0.21090540263254304,0.1705997899960573,EPB41,1
REACTOME_SIGNALING_BY_BMP,REACTOME_SIGNALING_BY_BMP,1/45,28/21728,0.05643116445544938,0.2174259571665844,0.17587421739469258,ZFYVE16,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,2/45,186/21728,0.05676675851606455,0.21765205948110602,0.17605710985213344,SPAG9/TSC22D2,2
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,3/45,427/21728,0.058316665573421335,0.21853747134041182,0.1767733128292604,RPS6KA5/EPB41/ZNF493,3
REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,1/45,29/21728,0.05838787402224743,0.21853747134041182,0.1767733128292604,NAB1,1
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,1/45,29/21728,0.05838787402224743,0.21853747134041182,0.1767733128292604,RBL2,1
REACTOME_MYOGENESIS,REACTOME_MYOGENESIS,1/45,29/21728,0.05838787402224743,0.21853747134041182,0.1767733128292604,SPAG9,1
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,1/45,29/21728,0.05838787402224743,0.21853747134041182,0.1767733128292604,TRIT1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,2/45,190/21728,0.05893719430420942,0.21954803186307395,0.17759074761657515,PTBP2/RAD21,2
WANG_RESPONSE_TO_BEXAROTENE_DN,WANG_RESPONSE_TO_BEXAROTENE_DN,1/45,30/21728,0.060340615884498794,0.2212234783859118,0.17894600367629668,NAB1,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,2/45,193/21728,0.060583857833667286,0.2212234783859118,0.17894600367629668,PBX1/NFIB,2
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,2/45,195/21728,0.06169046296488247,0.2212234783859118,0.17894600367629668,DAPK1/NFIB,2
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1/45,31/21728,0.06228939790520127,0.2212234783859118,0.17894600367629668,DDX46,1
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1/45,31/21728,0.06228939790520127,0.2212234783859118,0.17894600367629668,EPB41,1
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,1/45,31/21728,0.06228939790520127,0.2212234783859118,0.17894600367629668,CASP8AP2,1
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,1/45,31/21728,0.06228939790520127,0.2212234783859118,0.17894600367629668,RPS6KA5,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1/45,31/21728,0.06228939790520127,0.2212234783859118,0.17894600367629668,PBX1,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,3/45,441/21728,0.06300383110941332,0.2212234783859118,0.17894600367629668,DAPK1/TSC22D2/NFIB,3
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,1/45,32/21728,0.0642342279321294,0.2212234783859118,0.17894600367629668,DAPK1,1
PID_NETRIN_PATHWAY,PID_NETRIN_PATHWAY,1/45,32/21728,0.0642342279321294,0.2212234783859118,0.17894600367629668,DAPK1,1
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,1/45,32/21728,0.0642342279321294,0.2212234783859118,0.17894600367629668,RBL2,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,2/45,200/21728,0.0644873388377676,0.2212234783859118,0.17894600367629668,CEP70/SDCCAG8,2
REACTOME_CILIUM_ASSEMBLY,REACTOME_CILIUM_ASSEMBLY,2/45,202/21728,0.06561804184046686,0.2212234783859118,0.17894600367629668,CEP70/SDCCAG8,2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,CEP70,1
BURTON_ADIPOGENESIS_12,BURTON_ADIPOGENESIS_12,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,CASP8AP2,1
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,ZBTB5,1
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,KLHL24,1
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,NR1D2,1
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,POLG2,1
PID_SYNDECAN_2_PATHWAY,PID_SYNDECAN_2_PATHWAY,1/45,33/21728,0.06617511379786767,0.2212234783859118,0.17894600367629668,EPB41,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,2/45,203/21728,0.06618591823586031,0.2212234783859118,0.17894600367629668,FOXN3/NFIB,2
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,3/45,452/21728,0.06680728664416616,0.2212234783859118,0.17894600367629668,PBX1/LARS1/RFX5,3
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,SPAG9,1
MURAKAMI_UV_RESPONSE_6HR_UP,MURAKAMI_UV_RESPONSE_6HR_UP,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,DAPK1,1
PID_MAPK_TRK_PATHWAY,PID_MAPK_TRK_PATHWAY,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,RPS6KA5,1
VALK_AML_CLUSTER_6,VALK_AML_CLUSTER_6,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,CEP70,1
WP_16P112_DISTAL_DELETION_SYNDROME,WP_16P112_DISTAL_DELETION_SYNDROME,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,SDCCAG8,1
WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,FMR1,1
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,RPS6KA5,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/45,34/21728,0.06811206331983544,0.2212234783859118,0.17894600367629668,RPS6KA5,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,2/45,207/21728,0.06847404619160413,0.22148395187901584,0.17915669872093953,NR1D2/PER3,2
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1/45,35/21728,0.0700450843003193,0.22341284794816402,0.180716968207702,DAPK1,1
KEGG_PRIMARY_IMMUNODEFICIENCY,KEGG_PRIMARY_IMMUNODEFICIENCY,1/45,35/21728,0.0700450843003193,0.22341284794816402,0.180716968207702,RFX5,1
WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,1/45,35/21728,0.0700450843003193,0.22341284794816402,0.180716968207702,RAD21,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,2/45,210/21728,0.07020734534757826,0.22341284794816402,0.180716968207702,EPB41/ZFYVE16,2
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,2/45,211/21728,0.0707883411947476,0.22360359303488914,0.18087126047016613,RAD21/NFIB,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,3/45,466/21728,0.07179861710534274,0.22360359303488914,0.18087126047016613,SPAG9/NAB1/CEP170,3
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,2/45,213/21728,0.07195512425228387,0.22360359303488914,0.18087126047016613,KHDC4/RNF38,2
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,1/45,36/21728,0.0719741845264974,0.22360359303488914,0.18087126047016613,RPS6KA5,1
HATADA_METHYLATED_IN_LUNG_CANCER_DN,HATADA_METHYLATED_IN_LUNG_CANCER_DN,1/45,36/21728,0.0719741845264974,0.22360359303488914,0.18087126047016613,MKRN3,1
MARZEC_IL2_SIGNALING_DN,MARZEC_IL2_SIGNALING_DN,1/45,36/21728,0.0719741845264974,0.22360359303488914,0.18087126047016613,DAPK1,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/45,214/21728,0.0725408939510446,0.22447693954929548,0.1815777038807747,NR1D2/DAPK1,2
HOWLIN_CITED1_TARGETS_1_DN,HOWLIN_CITED1_TARGETS_1_DN,1/45,37/21728,0.07389937177047246,0.22689416488902872,0.18353297923258785,NR1D2,1
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1/45,37/21728,0.07389937177047246,0.22689416488902872,0.18353297923258785,CBR4,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,3/45,474/21728,0.07472517366174107,0.2274619613678921,0.1839922655232447,FOXN3/RSRC1/KLHL24,3
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/45,219/21728,0.07549317642307973,0.2274619613678921,0.1839922655232447,STRN/RAD21,2
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,2/45,219/21728,0.07549317642307973,0.2274619613678921,0.1839922655232447,CEP170/CEP170P1,2
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,1/45,38/21728,0.07582065378929737,0.2274619613678921,0.1839922655232447,RPS6KA5,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/45,38/21728,0.07582065378929737,0.2274619613678921,0.1839922655232447,DAPK1,1
WP_SLEEP_REGULATION,WP_SLEEP_REGULATION,1/45,38/21728,0.07582065378929737,0.2274619613678921,0.1839922655232447,PER3,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,2/45,221/21728,0.07668486429241315,0.2277950382083884,0.18426168886817543,NAB1/VPS13B,2
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/45,39/21728,0.07773803832500403,0.2277950382083884,0.18426168886817543,NAB1,1
REACTOME_NGF_STIMULATED_TRANSCRIPTION,REACTOME_NGF_STIMULATED_TRANSCRIPTION,1/45,39/21728,0.07773803832500403,0.2277950382083884,0.18426168886817543,NAB1,1
WP_NUCLEAR_RECEPTORS,WP_NUCLEAR_RECEPTORS,1/45,39/21728,0.07773803832500403,0.2277950382083884,0.18426168886817543,NR1D2,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,2/45,224/21728,0.07848372691185226,0.2277950382083884,0.18426168886817543,RSRC1/DAPK1,2
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,1/45,40/21728,0.07965153310463302,0.2277950382083884,0.18426168886817543,EYA1,1
DELPUECH_FOXO3_TARGETS_DN,DELPUECH_FOXO3_TARGETS_DN,1/45,40/21728,0.07965153310463302,0.2277950382083884,0.18426168886817543,LARS1,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/45,40/21728,0.07965153310463302,0.2277950382083884,0.18426168886817543,STRN,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/45,40/21728,0.07965153310463302,0.2277950382083884,0.18426168886817543,DAPK1,1
TOMLINS_PROSTATE_CANCER_UP,TOMLINS_PROSTATE_CANCER_UP,1/45,40/21728,0.07965153310463302,0.2277950382083884,0.18426168886817543,DAPK1,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/45,227/21728,0.08029598349067675,0.2277950382083884,0.18426168886817543,RPS6KA5/RBL2,2
EPPERT_CE_HSC_LSC,EPPERT_CE_HSC_LSC,1/45,41/21728,0.08156114584026086,0.2277950382083884,0.18426168886817543,DAPK1,1
EPPERT_LSC_R,EPPERT_LSC_R,1/45,41/21728,0.08156114584026086,0.2277950382083884,0.18426168886817543,NAB1,1
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,1/45,41/21728,0.08156114584026086,0.2277950382083884,0.18426168886817543,LARS1,1
ONO_AML1_TARGETS_DN,ONO_AML1_TARGETS_DN,1/45,41/21728,0.08156114584026086,0.2277950382083884,0.18426168886817543,FOXN3,1
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,1/45,41/21728,0.08156114584026086,0.2277950382083884,0.18426168886817543,NFIB,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,2/45,230/21728,0.08212140764493629,0.2277950382083884,0.18426168886817543,POLG2/RAD21,2
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,3/45,495/21728,0.08265836625670923,0.2277950382083884,0.18426168886817543,STRN/KLHL24/CEP170,3
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,3/45,496/21728,0.08304503885212428,0.2277950382083884,0.18426168886817543,EPB41/RBL2/LARS1,3
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,3/45,497/21728,0.0834325089319704,0.2277950382083884,0.18426168886817543,PBX1/PER3/EPB41L5,3
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,NFIB,1
ELLWOOD_MYC_TARGETS_DN,ELLWOOD_MYC_TARGETS_DN,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,NR1D2,1
PID_BMP_PATHWAY,PID_BMP_PATHWAY,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,ZFYVE16,1
REACTOME_TRNA_AMINOACYLATION,REACTOME_TRNA_AMINOACYLATION,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,LARS1,1
WP_MELATONIN_METABOLISM_AND_EFFECTS,WP_MELATONIN_METABOLISM_AND_EFFECTS,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,PER3,1
WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,1/45,42/21728,0.08346688422902782,0.2277950382083884,0.18426168886817543,EPB41,1
HUMMEL_BURKITTS_LYMPHOMA_UP,HUMMEL_BURKITTS_LYMPHOMA_UP,1/45,43/21728,0.08536875595316751,0.229793980065718,0.18587861786486365,PTBP2,1
REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1/45,43/21728,0.08536875595316751,0.229793980065718,0.18587861786486365,TRIT1,1
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,1/45,43/21728,0.08536875595316751,0.229793980065718,0.18587861786486365,PER3,1
ULE_SPLICING_VIA_NOVA2,ULE_SPLICING_VIA_NOVA2,1/45,43/21728,0.08536875595316751,0.229793980065718,0.18587861786486365,EPB41,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,2/45,237/21728,0.08643068253387187,0.23017342343123068,0.18618554674228383,RAD21/CASP8AP2,2
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/45,238/21728,0.08705188198336353,0.23017342343123068,0.18618554674228383,DAPK1/CEP170,2
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,2/45,238/21728,0.08705188198336353,0.23017342343123068,0.18618554674228383,RPS6KA5/DAPK1,2
PARK_HSC_MARKERS,PARK_HSC_MARKERS,1/45,44/21728,0.08726676868003402,0.23017342343123068,0.18618554674228383,SPAG9,1
PID_HNF3A_PATHWAY,PID_HNF3A_PATHWAY,1/45,44/21728,0.08726676868003402,0.23017342343123068,0.18618554674228383,NFIB,1
WP_GENES_CONTROLLING_NEPHROGENESIS,WP_GENES_CONTROLLING_NEPHROGENESIS,1/45,44/21728,0.08726676868003402,0.23017342343123068,0.18618554674228383,EYA1,1
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,2/45,242/21728,0.08955032824849496,0.23540654850607706,0.19041858215839094,MLLT10/RFX5,2
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1/45,46/21728,0.09105124773713968,0.23826201484106002,0.19272834734699376,FOXN3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,2/45,247/21728,0.0927034970467552,0.23826201484106002,0.19272834734699376,EPB41/NFIB,2
MELLMAN_TUT1_TARGETS_DN,MELLMAN_TUT1_TARGETS_DN,1/45,47/21728,0.09293772932794464,0.23826201484106002,0.19272834734699376,PTBP2,1
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,1/45,47/21728,0.09293772932794464,0.23826201484106002,0.19272834734699376,SDCCAG8,1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1/45,47/21728,0.09293772932794464,0.23826201484106002,0.19272834734699376,RBL2,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,1/45,47/21728,0.09293772932794464,0.23826201484106002,0.19272834734699376,RRN3,1
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,1/45,47/21728,0.09293772932794464,0.23826201484106002,0.19272834734699376,FOXN3,1
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,2/45,250/21728,0.09461107875810076,0.23826201484106002,0.19272834734699376,RSRC1/DDX46,2
HOFMANN_CELL_LYMPHOMA_UP,HOFMANN_CELL_LYMPHOMA_UP,1/45,48/21728,0.09482038244266455,0.23826201484106002,0.19272834734699376,MLLT10,1
SU_PANCREAS,SU_PANCREAS,1/45,48/21728,0.09482038244266455,0.23826201484106002,0.19272834734699376,EPB41,1
WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,1/45,48/21728,0.09482038244266455,0.23826201484106002,0.19272834734699376,RPS6KA5,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,VPS13B,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,PER3,1
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,SPAG9,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,RBL2,1
REACTOME_RECYCLING_PATHWAY_OF_L1,REACTOME_RECYCLING_PATHWAY_OF_L1,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,RPS6KA5,1
REACTOME_SIGNALING_BY_NOTCH3,REACTOME_SIGNALING_BY_NOTCH3,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,PBX1,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,RBL2,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,NR1D2,1
ZHAN_MULTIPLE_MYELOMA_PR_DN,ZHAN_MULTIPLE_MYELOMA_PR_DN,1/45,49/21728,0.09669921467467957,0.23826201484106002,0.19272834734699376,RSBN1,1
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,1/45,50/21728,0.09857423360265782,0.2391337889249662,0.19343351883042664,POLG2,1
CHUNG_BLISTER_CYTOTOXICITY_DN,CHUNG_BLISTER_CYTOTOXICITY_DN,1/45,50/21728,0.09857423360265782,0.2391337889249662,0.19343351883042664,RBL2,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/45,50/21728,0.09857423360265782,0.2391337889249662,0.19343351883042664,NFIB,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/45,50/21728,0.09857423360265782,0.2391337889249662,0.19343351883042664,RPS6KA5,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,ZHAN_MULTIPLE_MYELOMA_MS_UP,1/45,50/21728,0.09857423360265782,0.2391337889249662,0.19343351883042664,PBX1,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/45,258/21728,0.09975363650260992,0.24125033320323508,0.19514557553870893,EYA1/FMR1,2
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,1/45,51/21728,0.1004454467905842,0.2414376794415877,0.19529711849835138,CBR4,1
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,1/45,51/21728,0.1004454467905842,0.2414376794415877,0.19529711849835138,STRN,1
BROWNE_HCMV_INFECTION_1HR_UP,BROWNE_HCMV_INFECTION_1HR_UP,1/45,52/21728,0.10231286178778987,0.24443133545654358,0.1977186642771559,KLHL23,1
WP_NETRINUNC5B_SIGNALING_PATHWAY,WP_NETRINUNC5B_SIGNALING_PATHWAY,1/45,52/21728,0.10231286178778987,0.24443133545654358,0.1977186642771559,DAPK1,1
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,1/45,53/21728,0.10417648612897623,0.2451310390726949,0.19828464925660602,NR1D2,1
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1/45,53/21728,0.10417648612897623,0.2451310390726949,0.19828464925660602,ZBTB5,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,2/45,266/21728,0.10497408789271445,0.2451310390726949,0.19828464925660602,PBX1/EPB41L5,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,2/45,267/21728,0.10563193026045793,0.2451310390726949,0.19828464925660602,FOXN3/DAPK1,2
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,RBL2,1
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,RAD21,1
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,RSBN1,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,ZFYVE16,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,RAD21,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,PER3,1
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,1/45,54/21728,0.10603632733424462,0.2451310390726949,0.19828464925660602,TSC22D2,1
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,1/45,55/21728,0.10789239290912489,0.24580701688861498,0.19883144261513785,RAD21,1
NAGASHIMA_NRG1_SIGNALING_DN,NAGASHIMA_NRG1_SIGNALING_DN,1/45,55/21728,0.10789239290912489,0.24580701688861498,0.19883144261513785,TSC22D2,1
REACTOME_SIGNALING_BY_ALK_IN_CANCER,REACTOME_SIGNALING_BY_ALK_IN_CANCER,1/45,55/21728,0.10789239290912489,0.24580701688861498,0.19883144261513785,STRN,1
REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1/45,55/21728,0.10789239290912489,0.24580701688861498,0.19883144261513785,POLG2,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/45,55/21728,0.10789239290912489,0.24580701688861498,0.19883144261513785,RPS6KA5,1
MCCLUNG_CREB1_TARGETS_DN,MCCLUNG_CREB1_TARGETS_DN,1/45,56/21728,0.10974469034460166,0.24930441217010665,0.20166045928852874,EPB41,1
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SMIRNOV_RESPONSE_TO_IR_2HR_DN,1/45,57/21728,0.11159322711714237,0.25277313116447814,0.20446627992948277,RSBN1,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,1/45,58/21728,0.11343801068872306,0.25380765301510205,0.2053030968543212,PBX1,1
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,1/45,58/21728,0.11343801068872306,0.25380765301510205,0.2053030968543212,PER3,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/45,58/21728,0.11343801068872306,0.25380765301510205,0.2053030968543212,NFIB,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/45,279/21728,0.1136136695362251,0.25380765301510205,0.2053030968543212,NR1D2/TSC22D2,2
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,2/45,280/21728,0.11428589926157898,0.25380765301510205,0.2053030968543212,DAPK1/CEP170,2
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,2/45,280/21728,0.11428589926157898,0.25380765301510205,0.2053030968543212,EPB41/KLHL23,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/45,59/21728,0.11527904850685933,0.25380765301510205,0.2053030968543212,PBX1,1
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,1/45,59/21728,0.11527904850685933,0.25380765301510205,0.2053030968543212,VPS13B,1
PID_P53_REGULATION_PATHWAY,PID_P53_REGULATION_PATHWAY,1/45,59/21728,0.11527904850685933,0.25380765301510205,0.2053030968543212,FBXO11,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/45,59/21728,0.11527904850685933,0.25380765301510205,0.2053030968543212,STRN,1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/45,60/21728,0.11711634800462933,0.2564162939599962,0.20741320684590564,FMR1,1
WP_PREIMPLANTATION_EMBRYO,WP_PREIMPLANTATION_EMBRYO,1/45,60/21728,0.11711634800462933,0.2564162939599962,0.20741320684590564,PBX1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/45,61/21728,0.11894991660070608,0.2597073179115416,0.21007529130651015,RPS6KA5,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,2/45,289/21728,0.12038269073381715,0.2621074651434357,0.21201675230565845,ZFYVE16/FMR1,2
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,2/45,290/21728,0.1210651768690449,0.2628652735333406,0.212629737798497,MLLT10/SPAG9,2
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,2/45,291/21728,0.12174865089139299,0.26330117508962514,0.21298233528074673,NR1D2/SPAG9,2
LIU_COMMON_CANCER_GENES,LIU_COMMON_CANCER_GENES,1/45,63/21728,0.1226058906905888,0.26330117508962514,0.21298233528074673,LARS1,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,1/45,63/21728,0.1226058906905888,0.26330117508962514,0.21298233528074673,DAPK1,1
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1/45,63/21728,0.1226058906905888,0.26330117508962514,0.21298233528074673,RPS6KA5,1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1/45,64/21728,0.12442831094994422,0.2637491658125193,0.2133447115987166,EYA1,1
GOLDRATH_IMMUNE_MEMORY,GOLDRATH_IMMUNE_MEMORY,1/45,64/21728,0.12442831094994422,0.2637491658125193,0.2133447115987166,NR1D2,1
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,1/45,64/21728,0.12442831094994422,0.2637491658125193,0.2133447115987166,RBL2,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/45,64/21728,0.12442831094994422,0.2637491658125193,0.2133447115987166,FOXN3,1
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,2/45,295/21728,0.12449229073339016,0.2637491658125193,0.2133447115987166,STRN/RAD21,2
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,2/45,296/21728,0.12518060305000608,0.264191010491859,0.21370211642839537,DAPK1/STRN,2
BRIDEAU_IMPRINTED_GENES,BRIDEAU_IMPRINTED_GENES,1/45,65/21728,0.12624702983875724,0.264191010491859,0.21370211642839537,MKRN3,1
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,1/45,65/21728,0.12624702983875724,0.264191010491859,0.21370211642839537,DAPK1,1
KORKOLA_YOLK_SAC_TUMOR,KORKOLA_YOLK_SAC_TUMOR,1/45,65/21728,0.12624702983875724,0.264191010491859,0.21370211642839537,CEP70,1
MUELLER_PLURINET,MUELLER_PLURINET,2/45,299/21728,0.12725119900067336,0.264191010491859,0.21370211642839537,POLG2/PBX1,2
RAMASWAMY_METASTASIS_UP,RAMASWAMY_METASTASIS_UP,1/45,66/21728,0.12806205470406906,0.264191010491859,0.21370211642839537,VPS13B,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1/45,66/21728,0.12806205470406906,0.264191010491859,0.21370211642839537,RBL2,1
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,1/45,66/21728,0.12806205470406906,0.264191010491859,0.21370211642839537,FBXO11,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/45,66/21728,0.12806205470406906,0.264191010491859,0.21370211642839537,NFIB,1
WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,1/45,66/21728,0.12806205470406906,0.264191010491859,0.21370211642839537,MKRN3,1
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1/45,67/21728,0.12987339287867528,0.26614482275698836,0.2152825404382228,DAPK1,1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1/45,67/21728,0.12987339287867528,0.26614482275698836,0.2152825404382228,VPS13B,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,2/45,303/21728,0.13002495157593325,0.26614482275698836,0.2152825404382228,SPAG9/RNF38,2
JI_RESPONSE_TO_FSH_UP,JI_RESPONSE_TO_FSH_UP,1/45,68/21728,0.13168105168115274,0.2667559449004795,0.21577687253232838,NAB1,1
LINDVALL_IMMORTALIZED_BY_TERT_UP,LINDVALL_IMMORTALIZED_BY_TERT_UP,1/45,68/21728,0.13168105168115274,0.2667559449004795,0.21577687253232838,NAB1,1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,1/45,68/21728,0.13168105168115274,0.2667559449004795,0.21577687253232838,KLHL24,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/45,68/21728,0.13168105168115274,0.2667559449004795,0.21577687253232838,RBL2,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/45,69/21728,0.133485038415887,0.26852094255872994,0.21720456583028375,RRN3,1
RHODES_UNDIFFERENTIATED_CANCER,RHODES_UNDIFFERENTIATED_CANCER,1/45,69/21728,0.133485038415887,0.26852094255872994,0.21720456583028375,RAD21,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,2/45,310/21728,0.13491348227414773,0.26852094255872994,0.21720456583028375,POLG2/PBX1,2
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/45,70/21728,0.13528536037310057,0.26852094255872994,0.21720456583028375,RPS6KA5,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,1/45,70/21728,0.13528536037310057,0.26852094255872994,0.21720456583028375,ZBTB5,1
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/45,70/21728,0.13528536037310057,0.26852094255872994,0.21720456583028375,EPB41L5,1
MAHAJAN_RESPONSE_TO_IL1A_DN,MAHAJAN_RESPONSE_TO_IL1A_DN,1/45,70/21728,0.13528536037310057,0.26852094255872994,0.21720456583028375,FOXN3,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/45,70/21728,0.13528536037310057,0.26852094255872994,0.21720456583028375,SPAG9,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/45,313/21728,0.1370215446433924,0.26900785029723995,0.2175984218287571,MLLT10/PER3,2
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/45,71/21728,0.1370820248288772,0.26900785029723995,0.2175984218287571,RAD21,1
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,1/45,71/21728,0.1370820248288772,0.26900785029723995,0.2175984218287571,RPS6KA5,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1/45,71/21728,0.1370820248288772,0.26900785029723995,0.2175984218287571,NFIB,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,2/45,314/21728,0.13772591596248465,0.26900785029723995,0.2175984218287571,KLHL24/CBR4,2
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,1/45,72/21728,0.1388750390451905,0.26900785029723995,0.2175984218287571,RPS6KA5,1
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,1/45,72/21728,0.1388750390451905,0.26900785029723995,0.2175984218287571,RFX5,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/45,72/21728,0.1388750390451905,0.26900785029723995,0.2175984218287571,NFIB,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,2/45,317/21728,0.13984399376911985,0.26900785029723995,0.2175984218287571,SPAG9/KLHL24,2
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,2/45,317/21728,0.13984399376911985,0.26900785029723995,0.2175984218287571,PER3/ZNF493,2
CHESLER_BRAIN_QTL_CIS,CHESLER_BRAIN_QTL_CIS,1/45,73/21728,0.14066441026993082,0.26900785029723995,0.2175984218287571,PER3,1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/45,73/21728,0.14066441026993082,0.26900785029723995,0.2175984218287571,TSC22D2,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/45,73/21728,0.14066441026993082,0.26900785029723995,0.2175984218287571,PBX1,1
LINDVALL_IMMORTALIZED_BY_TERT_DN,LINDVALL_IMMORTALIZED_BY_TERT_DN,1/45,73/21728,0.14066441026993082,0.26900785029723995,0.2175984218287571,PER3,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/45,73/21728,0.14066441026993082,0.26900785029723995,0.2175984218287571,RBL2,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,1/45,74/21728,0.14245014573692927,0.2712118435298238,0.2193812153368335,MLLT10,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,2/45,322/21728,0.14339029740730674,0.2712118435298238,0.2193812153368335,PBX1/NAB1,2
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,2/45,323/21728,0.14410192887238135,0.2712118435298238,0.2193812153368335,MLLT10/PBX1,2
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,2/45,323/21728,0.14410192887238135,0.2712118435298238,0.2193812153368335,DAPK1/CEP170,2
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/45,75/21728,0.14423225266598771,0.2712118435298238,0.2193812153368335,DDX46,1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1/45,75/21728,0.14423225266598771,0.2712118435298238,0.2193812153368335,TSC22D2,1
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1/45,75/21728,0.14423225266598771,0.2712118435298238,0.2193812153368335,STRN,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,2/45,327/21728,0.146956154430974,0.27140067579328403,0.21953396033098105,POLG2/PER3,2
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,2/45,327/21728,0.146956154430974,0.27140067579328403,0.21953396033098105,DAPK1/TSC22D2,2
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,RBL2,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,RBL2,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,RBL2,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,PBX1,1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,NFIB,1
REACTOME_MEIOTIC_SYNAPSIS,REACTOME_MEIOTIC_SYNAPSIS,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,RAD21,1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,RAD21,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/45,77/21728,0.14778560971949817,0.27140067579328403,0.21953396033098105,TSC22D2,1
MORI_PRE_BI_LYMPHOCYTE_DN,MORI_PRE_BI_LYMPHOCYTE_DN,1/45,78/21728,0.14955687421363784,0.27211042391647994,0.22010807023644552,FBXO11,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/45,78/21728,0.14955687421363784,0.27211042391647994,0.22010807023644552,STRN,1
REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,1/45,78/21728,0.14955687421363784,0.27211042391647994,0.22010807023644552,EYA1,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/45,78/21728,0.14955687421363784,0.27211042391647994,0.22010807023644552,RFX5,1
BASSO_HAIRY_CELL_LEUKEMIA_UP,BASSO_HAIRY_CELL_LEUKEMIA_UP,1/45,79/21728,0.15132453890926778,0.2728954946819899,0.22074310805935704,DAPK1,1
BILD_CTNNB1_ONCOGENIC_SIGNATURE,BILD_CTNNB1_ONCOGENIC_SIGNATURE,1/45,79/21728,0.15132453890926778,0.2728954946819899,0.22074310805935704,FBXO11,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/45,79/21728,0.15132453890926778,0.2728954946819899,0.22074310805935704,PER3,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,2/45,334/21728,0.15197976978026057,0.2728954946819899,0.22074310805935704,POLG2/SPAG9,2
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,2/45,335/21728,0.1527003182226662,0.2728954946819899,0.22074310805935704,MLLT10/RSRC1,2
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/45,80/21728,0.1530886109564331,0.2728954946819899,0.22074310805935704,STRN,1
SU_TESTIS,SU_TESTIS,1/45,80/21728,0.1530886109564331,0.2728954946819899,0.22074310805935704,MLLT10,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1/45,80/21728,0.1530886109564331,0.2728954946819899,0.22074310805935704,NFIB,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,2/45,337/21728,0.1541435233646431,0.2728954946819899,0.22074310805935704,KHDC4/ZBTB5,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/45,81/21728,0.15484909749130726,0.2728954946819899,0.22074310805935704,RPS6KA5,1
GAVIN_FOXP3_TARGETS_CLUSTER_P2,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1/45,81/21728,0.15484909749130726,0.2728954946819899,0.22074310805935704,FOXN3,1
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1/45,81/21728,0.15484909749130726,0.2728954946819899,0.22074310805935704,PBX1,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/45,81/21728,0.15484909749130726,0.2728954946819899,0.22074310805935704,RPS6KA5,1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,1/45,81/21728,0.15484909749130726,0.2728954946819899,0.22074310805935704,EPB41,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1/45,82/21728,0.15660600563621885,0.2736852080928928,0.22138190128312207,RBL2,1
MCLACHLAN_DENTAL_CARIES_DN,MCLACHLAN_DENTAL_CARIES_DN,1/45,82/21728,0.15660600563621885,0.2736852080928928,0.22138190128312207,PER3,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/45,82/21728,0.15660600563621885,0.2736852080928928,0.22138190128312207,PBX1,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,2/45,341/21728,0.15703820464363188,0.2736852080928928,0.22138190128312207,RFX5/CASP8AP2,2
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/45,341/21728,0.15703820464363188,0.2736852080928928,0.22138190128312207,NAB1/RFX5,2
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,1/45,83/21728,0.15835934249967443,0.27416397181661695,0.2217691696494397,FBXO11,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/45,83/21728,0.15835934249967443,0.27416397181661695,0.2217691696494397,EYA1,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/45,83/21728,0.15835934249967443,0.27416397181661695,0.2217691696494397,SPAG9,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,1/45,84/21728,0.16010911517639048,0.2747724116345915,0.2222613320306593,NR1D2,1
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,1/45,84/21728,0.16010911517639048,0.2747724116345915,0.2222613320306593,PBX1,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/45,84/21728,0.16010911517639048,0.2747724116345915,0.2222613320306593,PTBP2,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/45,84/21728,0.16010911517639048,0.2747724116345915,0.2222613320306593,STRN,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/45,85/21728,0.1618553307473135,0.2759615834433588,0.2232232441406036,RBL2,1
SANA_TNF_SIGNALING_DN,SANA_TNF_SIGNALING_DN,1/45,85/21728,0.1618553307473135,0.2759615834433588,0.2232232441406036,NFIB,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/45,85/21728,0.1618553307473135,0.2759615834433588,0.2232232441406036,DAPK1,1
LAIHO_COLORECTAL_CANCER_SERRATED_DN,LAIHO_COLORECTAL_CANCER_SERRATED_DN,1/45,86/21728,0.16359799627965077,0.27712936438751185,0.22416785334144526,FMR1,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/45,86/21728,0.16359799627965077,0.27712936438751185,0.22416785334144526,DAPK1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,1/45,86/21728,0.16359799627965077,0.27712936438751185,0.22416785334144526,CEP70,1
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,1/45,87/21728,0.16533711882689295,0.2794730653719094,0.22606365539658932,DAPK1,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/45,88/21728,0.16707270542884245,0.2799981801003628,0.22648841674115325,PBX1,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/45,88/21728,0.16707270542884245,0.2799981801003628,0.22648841674115325,NFIB,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/45,88/21728,0.16707270542884245,0.2799981801003628,0.22648841674115325,RFX5,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1/45,88/21728,0.16707270542884245,0.2799981801003628,0.22648841674115325,RAD21,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,2/45,357/21728,0.16872055316013926,0.28050854927219404,0.22690125051614457,MLLT10/NR1D2,2
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/45,89/21728,0.1688047631116384,0.28050854927219404,0.22690125051614457,ZBTB5,1
REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,1/45,89/21728,0.1688047631116384,0.28050854927219404,0.22690125051614457,RRN3,1
WALLACE_PROSTATE_CANCER_RACE_DN,WALLACE_PROSTATE_CANCER_RACE_DN,1/45,89/21728,0.1688047631116384,0.28050854927219404,0.22690125051614457,CBR4,1
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,1/45,90/21728,0.17053329888778213,0.28218773247536155,0.22825952914841083,ZFYVE16,1
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,1/45,90/21728,0.17053329888778213,0.28218773247536155,0.22825952914841083,NR1D2,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,2/45,364/21728,0.17387970813694895,0.2866837494839455,0.23189632340739663,RSBN1/RFX5,2
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/45,92/21728,0.17397983270208905,0.2866837494839455,0.23189632340739663,EYA1,1
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,1/45,94/21728,0.17741236270001093,0.28930729685105516,0.2340184910915191,VPS13B,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1/45,94/21728,0.17741236270001093,0.28930729685105516,0.2340184910915191,RNF38,1
REACTOME_MITOCHONDRIAL_BIOGENESIS,REACTOME_MITOCHONDRIAL_BIOGENESIS,1/45,94/21728,0.17741236270001093,0.28930729685105516,0.2340184910915191,POLG2,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/45,94/21728,0.17741236270001093,0.28930729685105516,0.2340184910915191,RPS6KA5,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1/45,94/21728,0.17741236270001093,0.28930729685105516,0.2340184910915191,RBL2,1
CHEN_LIVER_METABOLISM_QTL_CIS,CHEN_LIVER_METABOLISM_QTL_CIS,1/45,95/21728,0.17912339365491925,0.2914927275626636,0.23578626951633694,CEP170,1
GUO_TARGETS_OF_IRS1_AND_IRS2,GUO_TARGETS_OF_IRS1_AND_IRS2,1/45,96/21728,0.18083094449324622,0.29366347597456927,0.23754217153962748,RBL2,1
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/45,97/21728,0.18253502213275286,0.2958196441161727,0.23928627969220342,RPS6KA5,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,2/45,377/21728,0.18353038385349305,0.2967401801506674,0.24003089434980995,MLLT10/POLG2,2
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/45,98/21728,0.18423563347776806,0.2967401801506674,0.24003089434980995,NAB1,1
KIM_MYC_AMPLIFICATION_TARGETS_DN,KIM_MYC_AMPLIFICATION_TARGETS_DN,1/45,98/21728,0.18423563347776806,0.2967401801506674,0.24003089434980995,RNF38,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,2/45,382/21728,0.18726426912308441,0.3003552282688879,0.242955079515747,NR1D2/CEP70,2
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,1/45,100/21728,0.18762648483463606,0.3003552282688879,0.242955079515747,KLHL24,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1/45,100/21728,0.18762648483463606,0.3003552282688879,0.242955079515747,EPB41,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,2/45,385/21728,0.18951006800809467,0.30275388913488294,0.2448953382047265,PBX1/ZFYVE16,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/45,102/21728,0.191003553530813,0.3032904910610485,0.24532939145690816,NR1D2,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/45,102/21728,0.191003553530813,0.3032904910610485,0.24532939145690816,DDX46,1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,1/45,102/21728,0.191003553530813,0.3032904910610485,0.24532939145690816,NFIB,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,2/45,388/21728,0.19175980537386583,0.30387743351584384,0.2458041647831387,EPB41/RBL2,2
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/45,103/21728,0.19268693649997581,0.3041203455602028,0.24600065450430222,RPS6KA5,1
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,1/45,103/21728,0.19268693649997581,0.3041203455602028,0.24600065450430222,RFX5,1
CHICAS_RB1_TARGETS_LOW_SERUM,CHICAS_RB1_TARGETS_LOW_SERUM,1/45,104/21728,0.19436689431997578,0.30554475787100194,0.24715285088266395,NFIB,1
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1/45,104/21728,0.19436689431997578,0.30554475787100194,0.24715285088266395,ZFYVE16,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,2/45,392/21728,0.19476535525318994,0.30556001842117225,0.24716519502663456,SDCCAG8/ZFYVE16,2
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/45,105/21728,0.1960434338018292,0.30634222458894184,0.24779791569803253,RPS6KA5,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/45,105/21728,0.1960434338018292,0.30634222458894184,0.24779791569803253,STRN,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,2/45,395/21728,0.19702377482781108,0.306519166726335,0.24794104285885413,KLHL24/VPS13B,2
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,2/45,395/21728,0.19702377482781108,0.306519166726335,0.24794104285885413,SPAG9/TSC22D2,2
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,1/45,106/21728,0.19771656174332297,0.306519166726335,0.24794104285885413,KHDC4,1
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,1/45,106/21728,0.19771656174332297,0.306519166726335,0.24794104285885413,NR1D2,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/45,107/21728,0.19938628492903887,0.3078931629749009,0.24905245806460444,DAPK1,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1/45,107/21728,0.19938628492903887,0.3078931629749009,0.24905245806460444,NFIB,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,1/45,108/21728,0.20105261013038,0.3083278763329048,0.24940409442222378,PBX1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,2/45,402/21728,0.20230683951894773,0.3083278763329048,0.24940409442222378,RPS6KA5/NFIB,2
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/45,109/21728,0.20271554410559423,0.3083278763329048,0.24940409442222378,NAB1,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/45,109/21728,0.20271554410559423,0.3083278763329048,0.24940409442222378,MLLT10,1
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,1/45,109/21728,0.20271554410559423,0.3083278763329048,0.24940409442222378,RRN3,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/45,109/21728,0.20271554410559423,0.3083278763329048,0.24940409442222378,CRB1,1
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,DAPK1,1
CHENG_IMPRINTED_BY_ESTRADIOL,CHENG_IMPRINTED_BY_ESTRADIOL,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,VPS13B,1
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,RPS6KA5,1
LEE_EARLY_T_LYMPHOCYTE_UP,LEE_EARLY_T_LYMPHOCYTE_UP,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,CEP70,1
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,RFX5,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/45,110/21728,0.20437509359980077,0.3083278763329048,0.24940409442222378,NAB1,1
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,1/45,111/21728,0.20603126534501304,0.30927844535074545,0.2501730025336149,PBX1,1
REACTOME_TRNA_PROCESSING,REACTOME_TRNA_PROCESSING,1/45,111/21728,0.20603126534501304,0.30927844535074545,0.2501730025336149,TRIT1,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,2/45,408/21728,0.2068491683783678,0.30927844535074545,0.2501730025336149,RBL2/NFIB,2
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/45,408/21728,0.2068491683783678,0.30927844535074545,0.2501730025336149,KHDC4/DDX46,2
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/45,112/21728,0.20768406606016665,0.30927844535074545,0.2501730025336149,NAB1,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,2/45,410/21728,0.2083659647158368,0.30927844535074545,0.2501730025336149,PBX1/EPB41L5,2
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,2/45,411/21728,0.2091248464045973,0.30927844535074545,0.2501730025336149,EPB41/EPB41L5,2
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/45,113/21728,0.20933350245114068,0.30927844535074545,0.2501730025336149,ZBTB5,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/45,113/21728,0.20933350245114068,0.30927844535074545,0.2501730025336149,RPS6KA5,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/45,113/21728,0.20933350245114068,0.30927844535074545,0.2501730025336149,STRN,1
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1/45,113/21728,0.20933350245114068,0.30927844535074545,0.2501730025336149,RBL2,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,2/45,412/21728,0.20988404449774736,0.30951005436253176,0.2503603493169535,TRIT1/ZFYVE16,2
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/45,114/21728,0.21097958121078453,0.30996252491902176,0.2507263493385417,SPAG9,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/45,114/21728,0.21097958121078453,0.30996252491902176,0.2507263493385417,RBL2,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,2/45,416/21728,0.21292391242995198,0.3122354387498923,0.25256489219892186,EPB41/LARS1,2
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1/45,116/21728,0.21426169254247596,0.3124484050804937,0.25273715905801286,KLHL23,1
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1/45,116/21728,0.21426169254247596,0.3124484050804937,0.25273715905801286,RNF38,1
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,1/45,116/21728,0.21426169254247596,0.3124484050804937,0.25273715905801286,NAB1,1
REACTOME_MEIOSIS,REACTOME_MEIOSIS,1/45,117/21728,0.21589773843529436,0.313722818943047,0.2537680228225531,RAD21,1
MOOTHA_PGC,MOOTHA_PGC,2/45,421/21728,0.21673033886597637,0.313722818943047,0.2537680228225531,VPS13B/MKRN3,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,2/45,421/21728,0.21673033886597637,0.313722818943047,0.2537680228225531,DAPK1/MKRN3,2
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/45,118/21728,0.2175304533383723,0.313722818943047,0.2537680228225531,DAPK1,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/45,118/21728,0.2175304533383723,0.313722818943047,0.2537680228225531,RAD21,1
REACTOME_SELENOAMINO_ACID_METABOLISM,REACTOME_SELENOAMINO_ACID_METABOLISM,1/45,118/21728,0.2175304533383723,0.313722818943047,0.2537680228225531,LARS1,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,2/45,423/21728,0.21825484895302644,0.3141910462950161,0.2541467683972006,EPB41/NFIB,2
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,2/45,425/21728,0.21978041597123227,0.3158087878489736,0.2554553473426812,RAD21/DDX46,2
REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,1/45,120/21728,0.22078591667469694,0.3166746907049485,0.25615576963410863,PBX1,1
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,1/45,121/21728,0.22240867832545808,0.3172653741629946,0.2566335690296622,CEP70,1
REACTOME_L1CAM_INTERACTIONS,REACTOME_L1CAM_INTERACTIONS,1/45,121/21728,0.22240867832545808,0.3172653741629946,0.2566335690296622,RPS6KA5,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1/45,121/21728,0.22240867832545808,0.3172653741629946,0.2566335690296622,DAPK1,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/45,430/21728,0.2235987357731823,0.3172722782726877,0.256639153711937,PTBP2/NAB1,2
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,1/45,122/21728,0.2240281354215543,0.3172722782726877,0.256639153711937,PTBP2,1
HOLLERN_EMT_BREAST_TUMOR_DN,HOLLERN_EMT_BREAST_TUMOR_DN,1/45,122/21728,0.2240281354215543,0.3172722782726877,0.256639153711937,EPB41L5,1
WP_FRAGILE_X_SYNDROME,WP_FRAGILE_X_SYNDROME,1/45,122/21728,0.2240281354215543,0.3172722782726877,0.256639153711937,FMR1,1
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,2/45,432/21728,0.22512773676982506,0.3182561170882779,0.25743497351187866,RAD21/CASP8AP2,2
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/45,434/21728,0.2266576441337762,0.319270444962631,0.25825545568157104,PER3/NFIB,2
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,2/45,434/21728,0.2266576441337762,0.319270444962631,0.25825545568157104,PBX1/DAPK1,2
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1/45,125/21728,0.22886674508480342,0.3206226849321583,0.25934927239724603,RBL2,1
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,2/45,437/21728,0.2289541329801599,0.3206226849321583,0.25934927239724603,RSBN1/NAB1,2
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,2/45,438/21728,0.22972004708986718,0.3206226849321583,0.25934927239724603,RPS6KA5/EPB41,2
EPPERT_HSC_R,EPPERT_HSC_R,1/45,126/21728,0.2304730496013606,0.3206226849321583,0.25934927239724603,DAPK1,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/45,126/21728,0.2304730496013606,0.3206226849321583,0.25934927239724603,RPS6KA5,1
REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,1/45,126/21728,0.2304730496013606,0.3206226849321583,0.25934927239724603,RAD21,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/45,126/21728,0.2304730496013606,0.3206226849321583,0.25934927239724603,DAPK1,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,2/45,440/21728,0.23125247785367256,0.3211385999876089,0.25976659219568204,FMR1/DDX46,2
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/45,127/21728,0.23207608231906918,0.3211475364485711,0.25977382083157485,DDX46,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1/45,127/21728,0.23207608231906918,0.3211475364485711,0.25977382083157485,NFIB,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,2/45,445/21728,0.23508688333708413,0.3247421622195925,0.2626814865148438,STRN/CEP70,2
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/45,130/21728,0.23686561474582313,0.3257047744446773,0.2634601362857709,DAPK1,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,2/45,449/21728,0.23815757091606712,0.3257047744446773,0.2634601362857709,RPS6KA5/RSRC1,2
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/45,131/21728,0.23845562527163267,0.3257047744446773,0.2634601362857709,RBL2,1
KEGG_TIGHT_JUNCTION,KEGG_TIGHT_JUNCTION,1/45,132/21728,0.2400423964372007,0.3257047744446773,0.2634601362857709,EPB41,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/45,132/21728,0.2400423964372007,0.3257047744446773,0.2634601362857709,EPB41,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/45,132/21728,0.2400423964372007,0.3257047744446773,0.2634601362857709,RPS6KA5,1
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1/45,132/21728,0.2400423964372007,0.3257047744446773,0.2634601362857709,TSC22D2,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,2/45,453/21728,0.24123080042449216,0.3257047744446773,0.2634601362857709,ZNF493/FMR1,2
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,1/45,133/21728,0.24162593469244875,0.3257047744446773,0.2634601362857709,KLHL24,1
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,1/45,133/21728,0.24162593469244875,0.3257047744446773,0.2634601362857709,NFIB,1
WHITFIELD_CELL_CYCLE_G1_S,WHITFIELD_CELL_CYCLE_G1_S,1/45,133/21728,0.24162593469244875,0.3257047744446773,0.2634601362857709,CASP8AP2,1
WP_MRNA_PROCESSING,WP_MRNA_PROCESSING,1/45,133/21728,0.24162593469244875,0.3257047744446773,0.2634601362857709,PTBP2,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,2/45,454/21728,0.24199947617772466,0.3257047744446773,0.2634601362857709,RPS6KA5/EPB41L5,2
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,2/45,454/21728,0.24199947617772466,0.3257047744446773,0.2634601362857709,ZNF493/KLHL23,2
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,2/45,454/21728,0.24199947617772466,0.3257047744446773,0.2634601362857709,EPB41/ZFYVE16,2
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1/45,135/21728,0.2447833382089667,0.3283271396454741,0.2655813477244761,KLHL23,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/45,135/21728,0.2447833382089667,0.3283271396454741,0.2655813477244761,PER3,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,2/45,459/21728,0.24584487573350158,0.32918922031777215,0.266278678280346,NAB1/FBXO11,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,2/45,461/21728,0.24738390866044332,0.33014032112269787,0.26704801655030064,SPAG9/KLHL24,2
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1/45,137/21728,0.24792788717009417,0.33014032112269787,0.26704801655030064,NR1D2,1
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,1/45,137/21728,0.24792788717009417,0.33014032112269787,0.26704801655030064,KLHL24,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,2/45,463/21728,0.24892339597619478,0.33014032112269787,0.26704801655030064,FOXN3/RSRC1,2
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,1/45,138/21728,0.24949535718432891,0.33014032112269787,0.26704801655030064,TSC22D2,1
EPPERT_PROGENITOR,EPPERT_PROGENITOR,1/45,138/21728,0.24949535718432891,0.33014032112269787,0.26704801655030064,TRIT1,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/45,138/21728,0.24949535718432891,0.33014032112269787,0.26704801655030064,TSC22D2,1
PECE_MAMMARY_STEM_CELL_UP,PECE_MAMMARY_STEM_CELL_UP,1/45,139/21728,0.2510596327251676,0.33165188457475925,0.26827070882972354,NFIB,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/45,140/21728,0.2526207201552184,0.33315417121141216,0.2694858971631083,RPS6KA5,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/45,142/21728,0.2557333560715216,0.336694167290144,0.27234937330018344,FOXN3,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/45,143/21728,0.25728491722119173,0.33760591808991103,0.27308688164765804,RPS6KA5,1
REACTOME_REPRODUCTION,REACTOME_REPRODUCTION,1/45,143/21728,0.25728491722119173,0.33760591808991103,0.27308688164765804,RAD21,1
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,1/45,144/21728,0.2588333155869573,0.3390716434189141,0.2742724958149513,RPS6KA5,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/45,145/21728,0.260378557469768,0.33996270128112566,0.27499326580125877,NFIB,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/45,145/21728,0.260378557469768,0.33996270128112566,0.27499326580125877,DAPK1,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/45,146/21728,0.26192064915831237,0.34028038055939425,0.27525023417419864,DAPK1,1
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/45,146/21728,0.26192064915831237,0.34028038055939425,0.27525023417419864,KHDC4,1
WEI_MIR34A_TARGETS,WEI_MIR34A_TARGETS,1/45,146/21728,0.26192064915831237,0.34028038055939425,0.27525023417419864,EPB41,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/45,147/21728,0.26345959692904186,0.34171492274954934,0.2764106245355937,KHDC4,1
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1/45,148/21728,0.2649954070461906,0.3423056787725123,0.27688848262836135,RAD21,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,2/45,484/21728,0.2651081899496587,0.3423056787725123,0.27688848262836135,FOXN3/RRN3,2
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,2/45,485/21728,0.2658795040228312,0.3423056787725123,0.27688848262836135,PBX1/NFIB,2
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,1/45,149/21728,0.2665280857618034,0.3423056787725123,0.27688848262836135,CEP170,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/45,149/21728,0.2665280857618034,0.3423056787725123,0.27688848262836135,RBL2,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,1/45,149/21728,0.2665280857618034,0.3423056787725123,0.27688848262836135,PBX1,1
GOLDRATH_HOMEOSTATIC_PROLIFERATION,GOLDRATH_HOMEOSTATIC_PROLIFERATION,1/45,150/21728,0.268057639315755,0.3431487044009502,0.27757039970292474,STRN,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/45,150/21728,0.268057639315755,0.3431487044009502,0.27757039970292474,RFX5,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,2/45,493/21728,0.27205078456582843,0.34730194882064697,0.28092992779921083,PBX1/VPS13B,2
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/45,153/21728,0.2726276112243501,0.34730194882064697,0.28092992779921083,NR1D2,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/45,153/21728,0.2726276112243501,0.34730194882064697,0.28092992779921083,KLHL24,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/45,155/21728,0.27565874720733363,0.3500287161631086,0.2831355893431332,STRN,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/45,155/21728,0.27565874720733363,0.3500287161631086,0.2831355893431332,RPS6KA5,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,1/45,156/21728,0.27716968015016397,0.35137962677101436,0.2842283307482157,RPS6KA5,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/45,157/21728,0.27867753127167494,0.3515899511710056,0.28439846056955587,ZFYVE16,1
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,1/45,157/21728,0.27867753127167494,0.3515899511710056,0.28439846056955587,RPS6KA5,1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1/45,157/21728,0.27867753127167494,0.3515899511710056,0.28439846056955587,RAD21,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/45,159/21728,0.2816840126122009,0.35481351588652227,0.28700597776276876,NAB1,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,1/45,160/21728,0.2831826550820632,0.3561305070312027,0.2880712819697956,SPAG9,1
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,1/45,161/21728,0.2846782402323459,0.3568693729228451,0.2886689450186131,MLLT10,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/45,161/21728,0.2846782402323459,0.3568693729228451,0.2886689450186131,RPS6KA5,1
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1/45,162/21728,0.28617077415869385,0.35759972732708006,0.289259723189442,RSRC1,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/45,162/21728,0.28617077415869385,0.35759972732708006,0.289259723189442,PBX1,1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1/45,163/21728,0.2876602629448788,0.35832165875542743,0.28984368807858335,CRB1,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/45,163/21728,0.2876602629448788,0.35832165875542743,0.28984368807858335,RPS6KA5,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,1/45,164/21728,0.28914671266282366,0.3590352545860654,0.29042091036558654,EYA1,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/45,164/21728,0.28914671266282366,0.3590352545860654,0.29042091036558654,TSC22D2,1
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,1/45,166/21728,0.29211051912257857,0.36157302052023116,0.2924736900953791,PTBP2,1
IBRAHIM_NRF1_DOWN,IBRAHIM_NRF1_DOWN,1/45,166/21728,0.29211051912257857,0.36157302052023116,0.2924736900953791,KLHL24,1
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,1/45,167/21728,0.293587887949194,0.3628303143523058,0.2934907055963475,EYA1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,1/45,170/21728,0.2980019290778887,0.36770724686847805,0.2974356195373788,KLHL24,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/45,171/21728,0.29946727434143317,0.36893617183756505,0.29842968767897315,NR1D2,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,1/45,172/21728,0.300929628688264,0.3701575714381463,0.2994176686067235,KLHL24,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1/45,173/21728,0.3023889980846747,0.3713714882727411,0.30039959678148603,TRIT1,1
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1/45,174/21728,0.30384538848533293,0.3725779646637624,0.3013755064375418,PER3,1
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,1/45,175/21728,0.3052988058333038,0.37377704265572714,0.30234543158438354,NR1D2,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/45,176/21728,0.30674925606007064,0.3749687640174425,0.30330940600848433,NFIB,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/45,177/21728,0.3081967450855574,0.3755699870344932,0.3037957307738501,CBR4,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,1/45,177/21728,0.3081967450855574,0.3755699870344932,0.3037957307738501,CEP170,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1/45,178/21728,0.3096412788181525,0.3767461999242537,0.3047471605119181,DAPK1,1
REACTOME_APOPTOSIS,REACTOME_APOPTOSIS,1/45,179/21728,0.311082863154727,0.37733199141915963,0.3052210028353721,DAPK1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,1/45,179/21728,0.311082863154727,0.37733199141915963,0.3052210028353721,NAB1,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/45,180/21728,0.31252150398066014,0.37849291545269476,0.30616006553291497,PBX1,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,1/45,182/21728,0.3153899785847829,0.38079343036503743,0.3080209346999901,NAB1,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/45,182/21728,0.3153899785847829,0.38079343036503743,0.3080209346999901,PBX1,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/45,183/21728,0.3168198240764608,0.3818960993814195,0.3089128753533914,DAPK1,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1/45,184/21728,0.31824674948451626,0.3818960993814195,0.3089128753533914,KHDC4,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,1/45,184/21728,0.31824674948451626,0.3818960993814195,0.3089128753533914,RPS6KA5,1
WP_CILIOPATHIES,WP_CILIOPATHIES,1/45,184/21728,0.31824674948451626,0.3818960993814195,0.3089128753533914,SDCCAG8,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/45,185/21728,0.3196707606371898,0.38302014917809635,0.3098221107587654,POLG2,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/45,187/21728,0.32251006343255695,0.3846629891623517,0.31115099163527576,RBL2,1
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,1/45,187/21728,0.32251006343255695,0.3846629891623517,0.31115099163527576,RSRC1,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/45,187/21728,0.32251006343255695,0.3846629891623517,0.31115099163527576,RAD21,1
REACTOME_MRNA_SPLICING,REACTOME_MRNA_SPLICING,1/45,188/21728,0.3239253666750034,0.3857656639493222,0.31204293695646257,DDX46,1
REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,1/45,191/21728,0.32815395314265094,0.39021029829065607,0.31563816816332696,RAD21,1
KONDO_PROSTATE_CANCER_WITH_H3K27ME3,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1/45,194/21728,0.3323566755711669,0.3934222093357488,0.31823625879040074,EYA1,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/45,194/21728,0.3323566755711669,0.3934222093357488,0.31823625879040074,NR1D2,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,1/45,194/21728,0.3323566755711669,0.3934222093357488,0.31823625879040074,PBX1,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/45,197/21728,0.33653368858339694,0.3977676379346617,0.3217512432202164,RRN3,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/45,199/21728,0.33930415686387305,0.3996694398160529,0.32328959642278826,PER3,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/45,200/21728,0.34068514589918,0.3996694398160529,0.32328959642278826,CASP8AP2,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/45,200/21728,0.34068514589918,0.3996694398160529,0.32328959642278826,NFIB,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/45,200/21728,0.34068514589918,0.3996694398160529,0.32328959642278826,RNF38,1
LEE_DIFFERENTIATING_T_LYMPHOCYTE,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1/45,200/21728,0.34068514589918,0.3996694398160529,0.32328959642278826,EPB41,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/45,206/21728,0.3489120038365715,0.40871063340617764,0.3306029497486692,NFIB,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/45,207/21728,0.35027335314552765,0.409694725554144,0.33139897446725985,EPB41,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/45,208/21728,0.35163191915586434,0.4106726425802517,0.33219000417633854,DAPK1,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,1/45,209/21728,0.35298770742900487,0.4116444184557831,0.3329760663550194,MLLT10,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,1/45,210/21728,0.35434072351551893,0.4126100869380709,0.3337571883093543,NFIB,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/45,211/21728,0.35569097295514174,0.41356968157210267,0.3345333971736306,TRIT1,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/45,215/21728,0.36106441466139494,0.4185791001826791,0.3385854781175012,FOXN3,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/45,215/21728,0.36106441466139494,0.4185791001826791,0.3385854781175012,KLHL24,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,1/45,216/21728,0.3624009135848474,0.4188928207024853,0.33883924428056933,NAB1,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/45,216/21728,0.3624009135848474,0.4188928207024853,0.33883924428056933,PBX1,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/45,217/21728,0.3637346788734622,0.4198171183473441,0.3395869016764374,KLHL23,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/45,218/21728,0.3650657159917131,0.4207355612455814,0.34032982321190725,SPAG9,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1/45,220/21728,0.3677196275216895,0.4231736855520468,0.3423020035803352,ZBTB5,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,1/45,222/21728,0.370362691677538,0.42559221587506557,0.34425833452328863,FBXO11,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/45,223/21728,0.3716801695383445,0.42648264709071354,0.34497859761991556,RFX5,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/45,224/21728,0.3729949517922748,0.4273673937445015,0.34569426251731467,KLHL23,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/45,229/21728,0.3795286172480974,0.4342205140567752,0.35123769986646874,EYA1,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,1/45,232/21728,0.3834168125956011,0.43803141671532336,0.3543203102933645,NAB1,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/45,233/21728,0.384707575687953,0.4388681487528753,0.35499713652971293,RPS6KA5,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/45,234/21728,0.3859956966041681,0.439699445696922,0.3556695663599047,FBXO11,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/45,236/21728,0.38856403304116793,0.44007396249331127,0.35597251017270654,FOXN3,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/45,236/21728,0.38856403304116793,0.44007396249331127,0.35597251017270654,ZBTB5,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/45,236/21728,0.38856403304116793,0.44007396249331127,0.35597251017270654,CEP70,1
REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1/45,236/21728,0.38856403304116793,0.44007396249331127,0.35597251017270654,RAD21,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1/45,237/21728,0.38984425910263953,0.44025515467625675,0.3561190751633307,NFIB,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/45,237/21728,0.38984425910263953,0.44025515467625675,0.3561190751633307,DAPK1,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1/45,238/21728,0.39112186406938754,0.440432356960657,0.35626241275510495,EPB41,1
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,1/45,238/21728,0.39112186406938754,0.440432356960657,0.35626241275510495,NFIB,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/45,239/21728,0.3923968531860408,0.4412359465010416,0.3569124302753838,DAPK1,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/45,240/21728,0.39366923168697743,0.442034308722806,0.35755821945704414,TRIT1,1
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1/45,242/21728,0.39620617772807853,0.4437670652970669,0.358959833185253,DDX46,1
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,1/45,243/21728,0.3974707556859225,0.4437670652970669,0.358959833185253,FBXO11,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/45,243/21728,0.3974707556859225,0.4437670652970669,0.358959833185253,TSC22D2,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/45,243/21728,0.3974707556859225,0.4437670652970669,0.358959833185253,CEP170,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/45,245/21728,0.39999214744407285,0.445317036672863,0.3602135933445952,RRN3,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/45,245/21728,0.39999214744407285,0.445317036672863,0.3602135933445952,PBX1,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/45,249/21728,0.4050040191116526,0.4502590650944257,0.3642111628726839,RPS6KA5,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,1/45,250/21728,0.4062505771050402,0.450370879555094,0.36430160874685513,NFIB,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1/45,250/21728,0.4062505771050402,0.450370879555094,0.36430160874685513,EYA1,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/45,251/21728,0.4074945813899027,0.4511137196795261,0.3649024865226112,FOXN3,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,1/45,257/21728,0.41490526484282453,0.4586716429908018,0.3710160337035546,FOXN3,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/45,259/21728,0.41735529361327095,0.4607321078371222,0.37268272818216386,NFIB,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/45,262/21728,0.42101153892142495,0.46346648402274515,0.37489454446195,EYA1,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/45,262/21728,0.42101153892142495,0.46346648402274515,0.37489454446195,EPB41,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/45,263/21728,0.4222252946629951,0.4641525616854743,0.3754495075104144,PER3,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/45,265/21728,0.42464534708402246,0.4648624551644034,0.3760237349930356,RNF38,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/45,265/21728,0.42464534708402246,0.4648624551644034,0.3760237349930356,RSRC1,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/45,265/21728,0.42464534708402246,0.4648624551644034,0.3760237349930356,EPB41,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1/45,266/21728,0.42585165372248024,0.4655346311903609,0.37656745311233153,NFIB,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/45,267/21728,0.42705548726932985,0.46620224026901835,0.37710747706239073,RPS6KA5,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/45,272/21728,0.43303773172142745,0.4720771943592815,0.3818596831297791,EPB41,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/45,274/21728,0.43541349054706724,0.47400970023544997,0.38342287256222274,NAB1,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/45,278/21728,0.44013584250742177,0.4784879283690643,0.387045277534371,CRB1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/45,285/21728,0.44830719464289925,0.4866981422504404,0.3936864576393009,LARS1,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/45,289/21728,0.45292406012354725,0.49103215345808016,0.3971922066274011,RAD21,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/45,290/21728,0.4540723607576458,0.4915990021425752,0.3976507262543396,FBXO11,1
MANALO_HYPOXIA_DN,MANALO_HYPOXIA_DN,1/45,292/21728,0.4563618963323889,0.49259927206150805,0.39845983704988736,MLLT10,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/45,293/21728,0.45750314071870346,0.49259927206150805,0.39845983704988736,TSC22D2,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/45,293/21728,0.45750314071870346,0.49259927206150805,0.39845983704988736,PBX1,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,1/45,293/21728,0.45750314071870346,0.49259927206150805,0.39845983704988736,RSRC1,1
REACTOME_TRANSLATION,REACTOME_TRANSLATION,1/45,295/21728,0.4597786062340321,0.49369670013654265,0.3993475383453486,LARS1,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/45,295/21728,0.4597786062340321,0.49369670013654265,0.3993475383453486,KLHL24,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,1/45,300/21728,0.4654265196985641,0.49907946041346707,0.4037016125481908,NR1D2,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/45,307/21728,0.47323670949060404,0.5067630158850337,0.40991678263634707,STRN,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/45,308/21728,0.47434330339718733,0.5072569203676044,0.4103162982483367,FBXO11,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/45,309/21728,0.47544762418836994,0.5077470551794276,0.41071276460208156,RFX5,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1/45,311/21728,0.47764946466927605,0.5094063490231356,0.41205495488144356,RAD21,1
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,1/45,314/21728,0.4809352908202339,0.5122156349386231,0.41432736507690954,CASP8AP2,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,1/45,321/21728,0.4885238228438644,0.5195936735524729,0.4202954048824074,TRIT1,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/45,325/21728,0.4928113096692003,0.5234455262162047,0.42341113945973957,DAPK1,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1/45,329/21728,0.4970636484384211,0.5272496999630216,0.426488306920671,FMR1,1
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,1/45,330/21728,0.49812127430039,0.5276594630729198,0.42681976121071863,EYA1,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1/45,341/21728,0.5096125818171894,0.5391056383691936,0.43607848610552147,ZFYVE16,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/45,345/21728,0.513727122813419,0.5427278474883701,0.43900846375113906,RBL2,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/45,347/21728,0.5157717156894831,0.5441564678280989,0.4401640639723742,LARS1,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1/45,353/21728,0.5218551904064819,0.5498367019564273,0.44475876253071117,FOXN3,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/45,366/21728,0.5347808133997973,0.5614773375155495,0.4541747848659326,RAD21,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/45,366/21728,0.5347808133997973,0.5614773375155495,0.4541747848659326,RBL2,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/45,367/21728,0.5357608182400282,0.5614773375155495,0.4541747848659326,KLHL24,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/45,367/21728,0.5357608182400282,0.5614773375155495,0.4541747848659326,EPB41,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,1/45,371/21728,0.5396606917779038,0.5648113232189511,0.4568716207636889,RPS6KA5,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/45,374/21728,0.5425645571553159,0.567095401494785,0.4587191944594216,LARS1,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/45,377/21728,0.54545050921734894,0.5693547148005793,0.4605467359576134,FBXO11,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,1/45,378/21728,0.5464085311875246,0.5695982831742631,0.4607437565786191,FMR1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1/45,383/21728,0.5511691047873737,0.5737998892223519,0.4641424040314726,CRB1,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/45,385/21728,0.5530596245470281,0.575006435044926,0.4651183698501879,CEP70,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,1/45,386/21728,0.5540019624046575,0.575225287252392,0.4652953977506961,MLLT10,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1/45,398/21728,0.5651595937168257,0.5860362014002969,0.474040264692352,DAPK1,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/45,399/21728,0.5660769785402078,0.5862141042590294,0.4741841689734214,NFIB,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,1/45,400/21728,0.5669924708729798,0.5863895817186343,0.4743261113674235,NFIB,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,1/45,407/21728,0.5733482470227872,0.5921836033638774,0.47901285179025305,SPAG9,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/45,411/21728,0.5769390680337209,0.5951103772631293,0.4813802971299453,NFIB,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/45,412/21728,0.5778321459498668,0.5952504150938339,0.48149357267533904,VPS13B,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,1/45,414/21728,0.5796127750880338,0.5963031953130818,0.4823451586568922,FMR1,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/45,419/21728,0.5840322819228376,0.600064540642288,0.48538768253373776,SPAG9,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/45,422/21728,0.5866621454187311,0.6019796949074707,0.4869368363788836,ZFYVE16,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/45,423/21728,0.5875351484909246,0.6020894742032161,0.4870256360234934,MLLT10,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/45,428/21728,0.591873192075435,0.605745220014703,0.4899827412466594,NFIB,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/45,431/21728,0.59445457116846,0.6061927022675365,0.49034470626703097,POLG2,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/45,432/21728,0.5953114779768094,0.6061927022675365,0.49034470626703097,STRN,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/45,433/21728,0.5961666143165467,0.6061927022675365,0.49034470626703097,ZBTB5,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/45,433/21728,0.5961666143165467,0.6061927022675365,0.49034470626703097,EYA1,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,1/45,433/21728,0.5961666143165467,0.6061927022675365,0.49034470626703097,KLHL24,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/45,446/21728,0.6071238911412156,0.616536664647281,0.4987118594441646,RPS6KA5,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/45,450/21728,0.6104364874195338,0.6191007472409723,0.500785926521424,POLG2,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,1/45,456/21728,0.6153542348677898,0.6224818900979187,0.5035209074851251,NAB1,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/45,456/21728,0.6153542348677898,0.6224818900979187,0.5035209074851251,KLHL24,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,1/45,463/21728,0.6210149178716673,0.6274006753819159,0.5074996758144866,RPS6KA5,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/45,467/21728,0.6242129364300932,0.6290145744026324,0.5088051465638007,NFIB,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/45,467/21728,0.6242129364300932,0.6290145744026324,0.5088051465638007,RSRC1,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1/45,470/21728,0.6265941193586336,0.6306056053980615,0.510092119539881,CEP70,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,1/45,481/21728,0.635199562464575,0.6384088651729363,0.5164041175364316,FMR1,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,1/45,482/21728,0.6359721901150243,0.6384088651729363,0.5164041175364316,FMR1,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1/45,484/21728,0.637512648369771,0.6390935816046702,0.5169579794954076,RAD21,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1/45,485/21728,0.6382804854448678,0.6390935816046702,0.5169579794954076,NR1D2,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/45,491/21728,0.6428542219884319,0.6428542219884319,0.5199999331471982,PER3,1
